,Canonical_Smiles,Label,Smiles,drug_name,drug_type
0,CC(C)(Oc1ccc([C@H]2CC2(Cl)Cl)cc1)C(=O)O,negative,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O,Ciprofibrate,4A11-Inducer
1,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,negative,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,Clofibrate,4A11-Substrate
2,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,negative,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Dexamethasone,4A11-Inducer
3,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O,Estrone,4A11-Substrate
4,CCO,negative,CCO,Ethanol,4A11-Inducer
5,Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1,negative,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F,Lansoprazole,4A11-Inducer
6,[Hg],negative,[Hg],"Mercury, Metallic",4A11-Inhibitor
7,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,negative,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,Phenobarbital,4A11-Inducer
8,CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,negative,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C,Rifampicin,4A11-Inducer
9,CCCC(CCC)C(=O)O,negative,CCCC(CCC)C(O)=O,Valproic Acid,4A11-Inducer
10,Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C,negative,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O,Aminophenazone,CP2CI-Substrate
11,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]1Cc4ccc(O)c5c4[C@]3(CCN1CC1CC1)[C@@H]2O5,negative,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6,Buprenorphine,CP2CI-Substrate
12,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,negative,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3,Clobazam,CP2CI-Substrate
13,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,negative,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3,Clotiazepam,CP2CI-Substrate
14,O=[P@@]1(N(CCCl)CCCl)NCCCO1,negative,ClCCN(CCCl)[P@]1(=O)NCCCO1,Cyclophosphamide,CP2CI-Substrate
15,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,negative,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2,Dapsone,CP2CI-Substrate
16,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,negative,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3,Diazepam,CP2CI-Substrate
17,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,negative,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl,Diclofenac,CP2CI-Substrate
18,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,negative,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3,Fluconazole,CP2CI-Inhibitor
19,O=[P@]1(NCCCl)OCCCN1CCCl,negative,ClCCN[P@@]1(=O)OCCCN1CCCl,Ifosfamide,CP2CI-Substrate
20,CN(C)CCCN1c2ccccc2CCc2ccccc21,negative,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,Imipramine,CP2CI-Substrate
21,CCN(CC)CC(=O)Nc1c(C)cccc1C,negative,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,Lidocain,CP2CI-Substrate
22,CC[C@@]1(c2ccccc2)NC(=O)N(C)C1=O,negative,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2,Mephenytoin,CP2CI-Substrate
23,CCC(=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1,negative,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,Methadone,CP2CI-Substrate
24,COc1ccc2[nH]c(S(=O)Cc3ncc(C)c(OC)c3C)nc2c1,negative,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1,Omeprazole,CP2CI-Substrate
25,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,negative,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1,Perphenazine,CP2CI-Substrate
26,Cc1cc(=O)n(-c2ccccc2)n1C,negative,CN1N(C(=O)C=C1C)C2=CC=CC=C2,Phenazone,CP2CI-Substrate
27,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,negative,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3,Phenytoin,CP2CI-Substrate
28,CC(C)c1cccc(C(C)C)c1O,negative,CC(C)C1=CC=CC(C(C)C)=C1O,Propofol,CP2CI-Substrate
29,O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1,negative,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,Thalidomide,CP2CI-Substrate
30,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,negative,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,Tolbutamide,CP2CI-Substrate
31,CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,negative,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C,Troleandomycin,CP2CI-Inhibitor
32,CC(=O)C[C@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,negative,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3,Warfarin,CP2CI-Substrate
33,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12,negative,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O,Aldosterone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inducer
34,CC[C@@]1(c2ccc(N)cc2)CCC(=O)NC1=O,negative,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2,Aminogluthetimide,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor
35,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,negative,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Androstanolone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate
36,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,negative,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,Metoclopramide,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor
37,O=P([O-])([O-])O,negative,OP([O-])([O-])=O,[32P]Natriumphosphat,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate
38,CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,negative,CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O,Cefmetazole,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
39,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O,negative,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O)C5=CC=C(O)C=C5)C(=O)C1=O,Cefoperazone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
40,CON=C(C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1,negative,CON=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NC(=O)C(O)=NN3C)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4,Ceftriaxone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
41,Cc1c2oc3c(C)ccc(C(=O)N[C@H]4C(=O)N[C@@H](C(C)C)C(=O)N5CCC[C@@H]5C(=O)N(C)CC(=O)N(C)[C@H](C(C)C)C(=O)O[C@H]4C)c3nc-2c(C(=O)N[C@H]2C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@@H]3C(=O)N(C)CC(=O)N(C)[C@H](C(C)C)C(=O)O[C@H]2C)c(N)c1=O,negative,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O,Dactinomycin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor
42,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,negative,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C,Docetaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor
43,CC(C)n1c(C=C[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,negative,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
44,NC(=O)NO,negative,NC(=O)NO,Hydroxycarbamide,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
45,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,negative,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O,Mitoxantrone,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor
46,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,negative,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C,Paclitaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
47,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)c1ccc(OS(=O)(=O)O)cc1,negative,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7,Pancreozymin (cholecystokinin),Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
48,O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21,negative,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
49,Cc1cc(C)c(NC(=O)CN(CC(=O)O)CC(=O)O)c(C)c1Br,negative,CC1=C(Br)C(C)=C(NC(=O)CN(CC(O)=O)CC(O)=O)C(C)=C1,Technetium (99mTc) Mebrofenin,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate
50,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,negative,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC,Telithromycin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor
51,CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,negative,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N,Anastrozole,19A-Inhibitor
52,c1ccc(-c2ccc([C@H](c3ccccc3)n3ccnc3)cc2)cc1,negative,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4,Bifonazole,19A-Inhibitor
53,CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2CO[P@@](=O)(O)O[C@H]2[C@H]1OC(=O)CCC,negative,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1,Bucladesine,19A-Inducer
54,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H]1CCC(=O)N1,negative,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@H]6CCC(=O)N6,Buserelin,19A-Inducer
55,Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1,negative,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl,Clofenotane,19A-Inhibitor
56,CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1,negative,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3,Clomifene,19A-Inhibitor
57,Clc1cccc(Cl)c1NC1=NCCN1,negative,ClC1=CC=CC(Cl)=C1NC2=NCCN2,Clonidine,19A-Inducer
58,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,negative,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4,Clotrimazole,19A-Inhibitor
59,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,negative,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C,Cyproterone,19A-Inhibitor
60,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,negative,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C,Danazol,19A-Inhibitor
61,CCCCOC(=O)c1ccccc1C(=O)OCCCC,negative,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC,Dibutylphthalate,19A-Inducer
62,CCC(=C(CC)c1ccc(O)cc1)c1ccc(O)cc1,negative,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2,Diethylstilbestrol,19A-Inducer
63,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,negative,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,Dinoprostone,19A-Inducer
64,NCCc1ccc(O)c(O)c1,negative,NCCC1=CC(O)=C(O)C=C1,Dopamine,19A-Inhibitor
65,Clc1ccc(CO[C@@H](C[C@H]2C=NC=N2)c2ccc(Cl)cc2Cl)cc1,negative,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1,Econazole,19A-Inhibitor
66,CCOC(=O)c1cncn1[C@@H](C)c1ccccc1,negative,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2,Etomidate,19A-Inhibitor
67,CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)cc(OC)c(C)c1C,negative,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,Etretinate,19A-Inhibitor
68,C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,negative,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O,Exemestane,19A-Inhibitor
69,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O,Formestane,19A-Inhibitor
70,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O,negative,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,Glutathione,19A-Inducer
71,Clc1ccc([C@H](Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1,negative,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl,Isoconazole,19A-Inhibitor
72,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,negative,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1,Isoprenaline,19A-Inducer
73,CC[C@H](C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,negative,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4,Itraconazole,19A-Inhibitor
74,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,negative,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N,Letrozole,19A-Inhibitor
75,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1,negative,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,Levacetylmethadol,19A-Substrate
76,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,negative,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Levonorgestrel,19A-Inhibitor
77,O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1,negative,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F,Mefloquine,19A-Inhibitor
78,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,negative,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,19A-Inhibitor
79,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,negative,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,Methyltestosterone,19A-Inducer
80,Clc1ccc(CO[C@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,negative,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1,Miconazole,19A-Inhibitor
81,C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,Nandrolone,19A-Substrate
82,NC[C@@H](O)c1ccc(O)c(O)c1,negative,NC[C@@H](O)C1=CC(O)=C(O)C=C1,Norepinephrine,19A-Inhibitor
83,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,negative,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Oxycodone,19A-Inhibitor
84,CNC[C@H](O)c1cccc(O)c1,negative,CNC[C@H](O)C1=CC(O)=CC=C1,Phenylephrine,19A-Inducer
85,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O,negative,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O,Prasterone,19A-Substrate
86,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,negative,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2,Raloxifene,19A-Inhibitor
87,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,negative,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1,Terbinafine,19A-Inhibitor
88,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,negative,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,Tinidazole,19A-Inhibitor
89,Clc1ccc([C@@H](Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,negative,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3,Tioconazole,19A-Inhibitor
90,C=CCN,negative,NCC=C,Trastuzumab,19A-Inhibitor
91,Cc1c(C)c2c(c(C)c1O)CC[C@](C)(COc1ccc(C[C@@H]3SC(=O)NC3=O)cc1)O2,negative,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O,Troglitazone,19A-Inhibitor
92,Cn1nnc2ccc([C@H](c3ccc(Cl)cc3)n3cncn3)cc21,negative,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4,Vorozole,19A-Inhibitor
93,OC[C@H]1O[C@@H](n2cnc3c(O)ncnc32)[C@H](O)[C@@H]1O,negative,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(O)N=CN=C23,Inosine,Solute_carrier_family_28_member_3-Inhibitor
94,S=c1[nH]cnc2nc[nH]c12,negative,S=C1NC=NC2=C1NC=N2,Mercaptopurine,Solute_carrier_family_28_member_3-Substrate
95,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,negative,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,Ribavirin,Solute_carrier_family_28_member_3-Substrate
96,Nc1nc2[nH]cnc2c(=S)[nH]1,negative,NC1=NC2=C(N=CN2)C(=S)N1,Tioguanine,Solute_carrier_family_28_member_3-Substrate
97,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,negative,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1,Tretinoin,Solute_carrier_family_28_member_3-Inducer
98,N[Pt](N)(Cl)Cl,negative,N[Pt](N)(Cl)Cl,Cisplatin,Probable_low_affinity_copper_uptake_protein_2-Substrate
99,[Ag],negative,[Ag],Silver,Probable_low_affinity_copper_uptake_protein_2-Inhibitor
100,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,negative,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O,Cefalexin,Multidrug_and_toxin_extrusion_protein_1-Substrate
101,CCN(CC)CCC[C@@H](C)Nc1ccnc2cc(Cl)ccc12,negative,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2,Chloroquine,Multidrug_and_toxin_extrusion_protein_1-Inhibitor
102,COc1ccccc1OC[C@H]1CNC(=O)O1,negative,COC1=C(OC[C@H]2CNC(=O)O2)C=CC=C1,Mephenoxalone,Multidrug_and_toxin_extrusion_protein_1-Substrate
103,CN(C)C(=N)NC(=N)N,negative,CN(C)C(=N)NC(N)=N,Metformin,Multidrug_and_toxin_extrusion_protein_1-Substrate
104,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,negative,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC,Trimethoprim,Multidrug_and_toxin_extrusion_protein_1-Inhibitor
105,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,negative,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O,Acarbose,2E1-Inducer
106,CC(=O)O,negative,CC(O)=O,Acetic Acid,2E1-Substrate
107,C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,negative,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23,Ademetionine,2E1-Inhibitor
108,Oc1ncnc2[nH]ncc12,negative,OC1=NC=NC2=C1C=NN2,Allopurinol,2E1-Inhibitor
109,Cc1nc[nH]c1CN1CCc2c(c3ccccc3n2C)C1=O,negative,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4,Alosetron,2E1-Inhibitor
110,Cn1c(=O)c2[nH]cnc2n(C)c1=O,negative,CN1C(=O)N(C)C2=C(NC=N2)C1=O,Aminophylline,2E1-Substrate
111,CN(C)CCC=C1c2ccccc2CCc2ccccc21,negative,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2,Amitriptyline,2E1-Substrate
112,CN1CCC[C@H](n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,negative,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O,Azelastine,2E1-Inhibitor
113,CCOC(=O)c1ccc(N)cc1,negative,CCOC(=O)C1=CC=C(N)C=C1,Benzocaine,2E1-Inhibitor
114,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,negative,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3,Benzydamine,2E1-Substrate
115,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,negative,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1,Bromazepam,2E1-Inhibitor
116,CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1,negative,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2,Brompheniramine,2E1-Substrate
117,C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1,negative,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Bupropion,2E1-Substrate
118,Cn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,Caffeine,2E1-Substrate
119,COc1cc(CNC(=O)CCCCC=CC(C)C)ccc1O,negative,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1,Capsaicin,2E1-Substrate
120,NC(N)=O,negative,NC(N)=O,Carbamide,2E1-Inducer
121,CN(C)CCO[C@@H](c1ccc(Cl)cc1)c1ccccn1,negative,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2,Carbinoxamine,2E1-Substrate
122,COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12,negative,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1,Carvedilol,2E1-Substrate
123,ClC(Cl)Cl,negative,ClC(Cl)Cl,Chloroform,2E1-Substrate
124,Cc1cc(O)cc(C)c1Cl,negative,CC1=CC(O)=CC(C)=C1Cl,Chloroxylenol,2E1-Substrate
125,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,negative,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,Chlorpromazine,2E1-Inhibitor
126,Oc1nc2cc(Cl)ccc2o1,negative,OC1=NC2=C(O1)C=CC(Cl)=C2,Chlorzoxazone,2E1-Inhibitor
127,CNC(=NC#N)NCCSCc1nc[nH]c1C,negative,CNC(NCCSCC1=C(C)NC=N1)=N/C#N,Cimetidine,2E1-Inhibitor
128,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,negative,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O,Ciprofloxacin,2E1-Inducer
129,CN(C)CCC[C@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,negative,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3,Citalopram,2E1-Substrate
130,Cc1ncsc1CCCl,negative,CC1=C(CCCl)SC=N1,Clomethiazole,2E1-Inhibitor
131,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,negative,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3,Clozapine,2E1-Inhibitor
132,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,negative,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O,Colchicine,2E1-Inducer
133,CN(C)N=Nc1[nH]cnc1C(N)=O,negative,CN(C)N=NC1=C(N=CN1)C(N)=O,Dacarbazine,2E1-Substrate
134,CNCCCN1c2ccccc2CCc2ccccc21,negative,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,Desipramine,2E1-Inhibitor
135,CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1,negative,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F,Dexfenfluramine,2E1-Inhibitor
136,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,negative,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1,Dextromethorphan,2E1-Substrate
137,CCN(CC)C(=O)c1cccc(C)c1,negative,CCN(CC)C(=O)C1=CC=CC(C)=C1,Diethyltoluamide,2E1-Substrate
138,CCN(CC)C(=S)SSC(=S)N(CC)CC,negative,CCN(CC)C(=S)SSC(=S)N(CC)CC,Disulfiram,2E1-Substrate
139,CCN[C@@H]1C[C@@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,negative,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Dorzolamide,2E1-Substrate
140,FC(F)OC(F)(F)[C@H](F)Cl,negative,FC(F)OC(F)(F)[C@H](F)Cl,Enflurane,2E1-Substrate
141,CCN(CC)C(=O)C(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,negative,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N,Entacapone,2E1-Inhibitor
142,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,negative,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,Eszopiclone,2E1-Substrate
143,CC[C@]1(C)CC(=O)NC1=O,negative,CC[C@]1(C)CC(=O)NC1=O,Ethosuximide,2E1-Substrate
144,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,negative,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26,Etoposide,2E1-Substrate
145,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,negative,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O,Etoricoxib,2E1-Inhibitor
146,NC(=O)OCC(COC(N)=O)c1ccccc1,negative,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,Felbamate,2E1-Substrate
147,O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1,negative,OC(=O)C1=CC=CC=C1NC2=CC=CC(=C2)C(F)(F)F,Flufenamic Acid,2E1-Inducer
148,C[C@@H]1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23,negative,C[C@@H]1CCC2=CC(F)=CC3=C2N1C=C(C(O)=O)C3=O,Flumequine,2E1-Inhibitor
149,CNCC[C@@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1,negative,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2,Fluoxetine,2E1-Substrate
150,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,negative,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1,Fluphenazine,2E1-Inhibitor
151,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,negative,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3,Flurazepam,2E1-Inhibitor
152,COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1,negative,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,Fluvoxamine,2E1-Substrate
153,Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,negative,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2,Folic Acid,2E1-Substrate
154,Cc1cn[nH]c1,negative,CC1=CNN=C1,Fomepizole,2E1-Inhibitor
155,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,negative,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl,Furosemide,2E1-Substrate
156,N[C@@H]1[C@@H](O)O[C@@H](CO)[C@H](O)[C@H]1O,negative,N[C@@H]1[C@@H](O)O[C@@H](CO)[C@H](O)[C@H]1O,Glucosamine,2E1-Substrate
157,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,negative,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,Glucose,2E1-Inhibitor
158,OCC(O)CO,negative,OCC(O)CO,Glycerol,2E1-Inducer
159,FC(F)(F)[C@@H](Cl)Br,negative,FC(F)(F)[C@@H](Cl)Br,Halothane,2E1-Substrate
160,NCCc1c[nH]cn1,negative,NCCC1=CNC=N1,Histamine,2E1-Inducer
161,CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,negative,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3,Ipriflavone,2E1-Inducer
162,FC(F)O[C@@H](Cl)C(F)(F)F,negative,FC(F)O[C@@H](Cl)C(F)(F)F,Isoflurane,2E1-Substrate
163,NNC(=O)c1ccncc1,negative,NNC(=O)C1=CC=NC=C1,Isoniazid,2E1-Inducer
164,CC(C)O,negative,CC(C)O,Isopropanol,2E1-Inducer
165,O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-],negative,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,Isosorbide Dinitrate,2E1-Inhibitor
166,CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,negative,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2,Ketoconazole,2E1-Inhibitor
167,C[N+](C)(C)C[C@H](O)CC(=O)[O-],negative,C[N+](C)(C)C[C@H](O)CC([O-])=O,Levocarnitine,2E1-Substrate
168,COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2,negative,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1,Levomepromazine,2E1-Inhibitor
169,CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21,negative,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3,Medazepam,2E1-Inhibitor
170,CC(=O)[C@H]1CC[C@H]2[C@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@@H]3[C@H](O)C[C@]12C,negative,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14,Medrysone,2E1-Inhibitor
171,CC1=CC(=O)c2ccccc2C1=O,negative,CC1=CC(=O)C2=C(C=CC=C2)C1=O,Menadione,2E1-Substrate
172,CCCC(C)(COC(N)=O)COC(N)=O,negative,CCCC(C)(COC(N)=O)COC(N)=O,Meprobamate,2E1-Substrate
173,CC(=O)N=c1sc(S(N)(=O)=O)nn1C,negative,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,Methazolamide,2E1-Inhibitor
174,COC(F)(F)C(Cl)Cl,negative,COC(F)(F)C(Cl)Cl,Methoxyflurane,2E1-Substrate
175,CC(C)(C(=O)c1cccnc1)c1cccnc1,negative,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2,Metyrapone,2E1-Inhibitor
176,Cc1cccc(C)c1OC[C@H](C)N,negative,C[C@H](N)COC1=C(C)C=CC=C1C,Mexiletine,2E1-Substrate
177,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,negative,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5,Mizolastine,2E1-Inhibitor
178,CCCCCCCCC=CCCCCCCCC(=O)O,negative,CCCCCCCCC=CCCCCCCCC(O)=O,Monoethanolamine Oleate,2E1-Substrate
179,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)[C@@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3,Nicardipine,2E1-Substrate
180,NC(=O)c1cccnc1,negative,NC(=O)C1=CC=CN=C1,Nicotinamide,2E1-Inhibitor
181,CN1CCC[C@H]1c1cccnc1,negative,CN1CCC[C@H]1C2=CC=CN=C2,Nicotine,2E1-Inducer
182,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],negative,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC,Nifedipine,2E1-Inhibitor
183,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)[C@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N,Nilvadipine,2E1-Substrate
184,CNCCC=C1c2ccccc2CCc2ccccc21,negative,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2,Nortriptyline,2E1-Inhibitor
185,Cc1nccn1C[C@H]1CCc2c(c3ccccc3n2C)C1=O,negative,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14,Ondansetron,2E1-Substrate
186,N[C@@H]1CCCC[C@H]1N,negative,N[C@@H]1CCCC[C@H]1N,Oxaliplatin,2E1-Substrate
187,CC(=O)Nc1ccc(O)cc1,negative,CC(=O)NC1=CC=C(O)C=C1,Paracetamol,2E1-Inducer
188,CCOP(=O)(OCC)Oc1ccc([N+](=O)[O-])cc1,negative,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,Paraoxon,2E1-Substrate
189,C#CCN(C)Cc1ccccc1,negative,CN(CC#C)CC1=CC=CC=C1,Pargyline,2E1-Inhibitor
190,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,negative,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1,Perazine,2E1-Substrate
191,CCOc1ccc(NC(C)=O)cc1,negative,CCOC1=CC=C(NC(C)=O)C=C1,Phenacetin,2E1-Substrate
192,Oc1ccccc1,negative,OC1=CC=CC=C1,Phenol,2E1-Substrate
193,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C,negative,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,Pilocarpine,2E1-Substrate
194,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,negative,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5,Pimozide,2E1-Inhibitor
195,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,negative,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,Proguanil,2E1-Substrate
196,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,negative,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C,Quinidine,2E1-Substrate
197,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,negative,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,Retinol (vit A),2E1-Inducer
198,CC(C)c1nc(CN(C)C(=O)N[C@@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,negative,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4,Ritonavir,2E1-Inhibitor
199,O=C(O)c1ccccc1O,negative,OC(=O)C1=C(O)C=CC=C1,Salicylic Acid,2E1-Inducer
200,C#CCN(C)[C@H](C)Cc1ccccc1,negative,C[C@H](CC1=CC=CC=C1)N(C)CC#C,Selegiline,2E1-Inhibitor
201,FCOC(C(F)(F)F)C(F)(F)F,negative,FCOC(C(F)(F)F)C(F)(F)F,Sevoflurane,2E1-Substrate
202,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,negative,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4,Sildenafil,2E1-Inhibitor
203,[Cl-].[Na+],negative,[Na+].[Cl-],Sodium Chloride,2E1-Inducer
204,CO[C@@H](CNC(=O)c1ccccc1OCC(=O)[O-])C[Hg]O,negative,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O,Sodium Salicylate,2E1-Inducer
205,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,negative,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,Streptozocin,2E1-Inducer
206,Clc1ccc(CS[C@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,negative,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1,Sulconazole,2E1-Inhibitor
207,Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,negative,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2,Sulfadiazine,2E1-Substrate
208,Nc1ccc(S(N)(=O)=O)cc1,negative,NC1=CC=C(C=C1)S(N)(=O)=O,Sulfanilamide,2E1-Inhibitor
209,O=c1[nH]c(=O)n([C@H]2CCCO2)cc1F,negative,FC1=CN([C@H]2CCCO2)C(=O)NC1=O,Tegafur,2E1-Substrate
210,CCCCCNC(=N)NN=Cc1c[nH]c2ccc(CO)cc12,negative,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2,Tegaserod,2E1-Inhibitor
211,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C,negative,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C,Tenofovir Disoproxil,2E1-Inhibitor
212,Cn1cnc2c1c(=O)[nH]c(=O)n2C,negative,CN1C=NC2=C1C(=O)NC(=O)N2C,Theobromine,2E1-Substrate
213,Cn1cc[nH]c1=S,negative,CN1C=CNC1=S,Thiamazole,2E1-Inhibitor
214,CCC[C@@H](C)[C@@]1(CC)C(=O)N=C(S)NC1=O,negative,CCC[C@@H](C)[C@]1(CC)C(=O)NC(S)=NC1=O,Thiopental,2E1-Inhibitor
215,CSc1ccc2c(c1)N(CC[C@@H]1CCCCN1C)c1ccccc1S2,negative,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1,Thioridazine,2E1-Inhibitor
216,O=S(=O)([O-])[S-],negative,[O-]S([S-])(=O)=O,Thiosulfate,2E1-Inhibitor
217,CN(C)C(=S)SSC(=S)N(C)C,negative,CN(C)C(=S)SSC(=S)N(C)C,Thiram,2E1-Substrate
218,Clc1ccccc1CN1CCc2sccc2C1,negative,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1,Ticlopidine,2E1-Inhibitor
219,C[C@H](S)C(=O)NCC(=O)O,negative,C[C@H](S)C(=O)NCC(O)=O,Tiopronin,2E1-Inhibitor
220,Cc1c(O)cc2c(c1C)O[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC2,negative,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2,Tocopherol (vit E),2E1-Inhibitor
221,COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4,negative,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1,Trabectedin,2E1-Substrate
222,N[C@H]1C[C@@H]1c1ccccc1,negative,N[C@H]1C[C@@H]1C2=CC=CC=C2,Tranylcypromine,2E1-Inhibitor
223,ClC=C(Cl)Cl,negative,ClC=C(Cl)Cl,Trichloroethylene,2E1-Substrate
224,CN1C(=O)OC(C)(C)C1=O,negative,CN1C(=O)OC(C)(C)C1=O,Trimethadione,2E1-Substrate
225,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,negative,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Ursodeoxycholic Acid,2E1-Inducer
226,CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32,negative,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC,Vincamine,2E1-Substrate
227,OCC(CO)N[C@H]1C[C@@](O)(CO)[C@H](O)[C@@H](O)[C@@H]1O,negative,OCC(CO)N[C@H]1C[C@@](O)(CO)[C@H](O)[C@@H](O)[C@@H]1O,Voglibose,2E1-Inducer
228,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,negative,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C,Zafirlukast,2E1-Inhibitor
229,CN1CCN(C(=O)O[C@@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,negative,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4,Zopiclone,2E1-Substrate
230,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,negative,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1,13_cis_retinoic_acid,2E1-Substrate
231,CC(=O)c1cc2ccccc2s1,negative,CC(=O)C1=CC2=CC=CC=C2S1,2_acetylbenzothiophene,2E1-Substrate
232,CCCCCCCC(C)O,negative,CCCCCCCC(C)O,2_nonanol,2E1-Substrate
233,CCCc1ccc2ccccc2n1,negative,CCCC1=CC=C2C=CC=CC2=N1,2n_propylquinoline,2E1-Substrate
234,Cc1c[nH]c2ccccc12,negative,CC1=C[NH]C2=CC=CC=C12,3_methylindole,2E1-Substrate
235,O=[N+]([O-])c1ccc(O)cc1,negative,OC1=CC=C(C=C1)[N](=O)=O,4_nitrophenol,2E1-Substrate
236,C=CC1CC=CCC1,negative,C=CC1CCC=CC1,4_vinylcyclohexene,2E1-Substrate
237,Cc1cc2ccccc2c2ccc3ccccc3c12,negative,CC1=CC2=CC=CC=C2C3=CC=C4C=CC=CC4=C13,5_methylchrysene,2E1-Substrate
238,Cc1cc2c3ccccc3ccc2c2ccccc12,negative,CC1=CC2=C3C=CC=CC3=CC=C2C4=CC=CC=C14,6_methylchrysene,2E1-Substrate
239,COc1ccc2c(C(F)(F)F)cc(=O)oc2c1,negative,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F,7_methoxy_4_trifluoro_methyl_coumarin,2E1-Substrate
240,COc1ccc2ccc(=O)oc2c1,negative,COC1=CC=C2C=C[C](=O)OC2=C1,7_methoxy_coumarin,2E1-Substrate
241,C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)NC(N)=O,negative,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1,ABT_438,2E1-Substrate
242,CC=O,negative,CC=O,acetaldehyde,2E1-Substrate
243,C=CC#N,negative,C=CC#N,acrylonitrile,2E1-Substrate
244,CCNc1nc(Cl)nc(NC(C)C)n1,negative,CCNC1=NC(=NC(=N1)Cl)NC(C)C,atrazine,2E1-Substrate
245,COc1ccc2c(C(=O)c3cc(OC)c(OC)c(OC)c3)c[nH]c2c1,negative,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC,BPR_0L075,2E1-Substrate
246,C[C@@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1,negative,C[C@@H](NC(C)(C)C)C(=O)C1=CC=CC(=C1)Cl,bupropion,2E1-Substrate
247,CNC(=O)Oc1cccc2ccccc12,negative,CNC(=O)OC1=CC=CC2=C1C=CC=C2,carbaryl,2E1-Substrate
248,O=c1[nH]c2cc(Cl)ccc2o1,negative,ClC1=CC2=C(O[C](=O)[NH]2)C=C1,chlorzoxazone,2E1-Substrate
249,C/C=C\C,negative,C\C=C/C,cis_2_butene,2E1-Substrate
250,COc1ccc(OC(F)(F)F)cc1CN,negative,COC1=CC=C(OC(F)(F)F)C=C1CN,cp_677_623,2E1-Substrate
251,C1=CCCCC1,negative,C1CCC=CC1,cyclohexene,2E1-Substrate
252,CN(C)N/N=C1\N=CN=C1C(N)=O,negative,CN(C)N\N=C1/N=CN=C1C(N)=O,dacarbazine,2E1-Substrate
253,CCN(CC)C(=S)SC,negative,CCN(CC)C(=S)SC,DDTC_Me,2E1-Substrate
254,CCN(CC)C(=O)SC,negative,CCN(CC)C(=O)SC,DETC_Me,2E1-Substrate
255,C=CCSSCC=C,negative,C=CCSSCC=C,diallylsulfide,2E1-Substrate
256,CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1,negative,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C,diazinion,2E1-Substrate
257,CN(C)C(=O)Nc1ccc(Cl)c(Cl)c1,negative,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl,diuron,2E1-Substrate
258,CN(C)C=O,negative,CN(C)C=O,DMF,2E1-Substrate
259,FC(F)OC(F)(F)C(F)Cl,negative,FC(F)OC(F)(F)C(F)Cl,enflurane,2E1-Substrate
260,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3OC5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,negative,COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4OC5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC,etoposide,2E1-Substrate
261,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)cc1OC,negative,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC,eupatilin,2E1-Substrate
262,FC(F)(F)C(Cl)Br,negative,FC(F)(F)C(Cl)Br,halothane,2E1-Substrate
263,CCCCCC,negative,CCCCCC,hexane,2E1-Substrate
264,O=[N+]([O-])NC1=NCCN1Cc1ccc(Cl)nc1,negative,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1,imidacloprid,2E1-Substrate
265,C=CC(=C)C,negative,CC(=C)C=C,isoprene,2E1-Substrate
266,C=CC1(C)CO1,negative,CC1(CO1)C=C,isoprene_epoxide_1,2E1-Substrate
267,C=C(C)C1CO1,negative,CC(=C)C1CO1,isoprene_epoxide_2,2E1-Substrate
268,CN1CCN(C(=O)NC(Cc2ccccc2)C(=O)NC(C=CS(=O)(=O)c2ccccc2)CCc2ccccc2)CC1,negative,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4,K11777,2E1-Substrate
269,CCCCC/C=C/C/C=C/CCCCCCCC(=O)O,negative,CCCCC\C=C\C\C=C\CCCCCCCC(O)=O,linoleic_acid,2E1-Substrate
270,CCN[C@H](C)Cc1ccc2c(c1)OCO2,negative,CCN[C@H](C)CC1=CC=C2OCOC2=C1,MDE_R,2E1-Substrate
271,COC(C)(C)C,negative,COC(C)(C)C,methyl_tert_butyl_ether,2E1-Substrate
272,COc1ccc(C(c2ccc(O)cc2)C(Cl)(Cl)Cl)cc1,negative,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl,mono_OH_methoxychlor,2E1-Substrate
273,COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1,negative,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1,muraglitazar,2E1-Substrate
274,CCN(C)C=O,negative,CCN(C)C=O,N_methyl_ethyl_formamide,2E1-Substrate
275,O=NN1CCCC1,negative,O=NN1CCCC1,N_nitroso_pyrrolidine,2E1-Substrate
276,COc1ccc2cc(CCC(C)=O)ccc2c1,negative,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1,nabumetone,2E1-Substrate
277,CCN(CC)N=O,negative,CCN(CC)N=O,NN_diethyl_nitrosoamine,2E1-Substrate
278,CN(C)N=O,negative,CN(C)N=O,NN_dimethyl_nitrosoamine,2E1-Substrate
279,CCCCN(C)N=O,negative,CCCCN(C)N=O,NN_methyl_butyl_nitrosoamine,2E1-Substrate
280,CCN(C)N=O,negative,CCN(C)N=O,NN_methyl_ethyl_nitrosoamine,2E1-Substrate
281,CN(CCCC(=O)c1cccnc1)N=O,negative,CN(CCCC(=O)C1=CC=CN=C1)N=O,NNK,2E1-Substrate
282,Oc1ccccc1-c1ccccc1,negative,OC1=C(C=CC=C1)C2=CC=CC=C2,O_phenylphenol,2E1-Substrate
283,Cc1ccc(O)cc1,negative,CC1=CC=C(O)C=C1,p_cresol,2E1-Substrate
284,CCOP(=S)(OCC)Oc1ccc([N+](=O)[O-])cc1,negative,CCO[P](=S)(OCC)OC1=CC=C(C=C1)[N](=O)=O,parathion,2E1-Substrate
285,CN(C)CCCN1c2ccccc2Sc2ccccc21,negative,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13,promazine,2E1-Substrate
286,c1ccc2ncccc2c1,negative,C1=CC=C2N=CC=CC2=C1,quinoline,2E1-Substrate
287,COCCCOc1ccnc(CSc2nc3ccccc3[nH]2)c1C,negative,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2,rabeprazole_thioether,2E1-Substrate
288,O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12,negative,O=[C]1[N]2CCC3=C([NH]C4=CC=CC=C34)C2=NC5=C1C=CC=C5,rutaecarpine,2E1-Substrate
289,O=c1[nH]c(=O)n(C2CCCO2)cc1F,negative,FC1=C[N](C2CCCO2)[C](=O)[NH][C]1=O,tegafur,2E1-Substrate
290,C/C=C/c1ccccc1,negative,C\C=C\C1=CC=CC=C1,trans_phenylpropene,2E1-Substrate
291,Cc1ccc(C)cc1,negative,CC1=CC=C(C)C=C1,xylene_para,2E1-Substrate
292,C[C@H](c1cc2ccccc2s1)N(O)C(N)=O,negative,C[C@@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1,zileuton_R,2E1-Substrate
293,CCOc1ccc2cc(C#N)c(=O)oc2c1,negative,CCOC1=CC=C2C=C(C#N)[C](=O)OC2=C1,3_cyano_7_ethoxycoumarin,2E1-Substrate
294,COc1ccc([N+](=O)[O-])cc1,negative,COC1=CC=C(C=C1)[N](=O)=O,4_nitroanisole,2E1-Substrate
295,CCOc1ccc2c(C(F)(F)F)cc(=O)oc2c1,negative,CCOC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F,7_ethoxy_4_trifluoro_methyl_coumarin,2E1-Substrate
296,CCOc1ccc2ccc(=O)oc2c1,negative,CCOC1=CC=C2C=C[C](=O)OC2=C1,7_ethoxy_coumarin,2E1-Substrate
297,COc1ccc2cc(C#N)c(=O)oc2c1,negative,COC1=CC=C2C=C(C#N)[C](=O)OC2=C1,7_methoxy_3_cyano_coumarin,2E1-Substrate
298,O=Cc1c2ccccc2cc2ccccc12,negative,O=CC1=C2C=CC=CC2=CC3=CC=CC=C13,9_anthraldehyde,2E1-Substrate
299,C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=O,negative,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O,ABT_761,2E1-Substrate
300,C=CC1CO1,negative,C=CC1CO1,butadienemonoxide,2E1-Substrate
301,Cc1c2ccccc2c(C)c2c1ccc1ccccc12,negative,CC1=C2C=CC=CC2=C(C)C3=C4C=CC=CC4=CC=C13,DMBA,2E1-Substrate
302,CCOC(C)(C)C,negative,CCOC(C)(C)C,ethyl_tert_butyl_ether,2E1-Substrate
303,c1ccc2[nH]ccc2c1,negative,[NH]1C=CC2=CC=CC=C12,indole,2E1-Substrate
304,CCCCCCCCCCCC(=O)O,negative,CCCCCCCCCCCC(O)=O,lauric_acid,2E1-Substrate
305,CCCCCCCCCCCCCC(=O)O,negative,CCCCCCCCCCCCCC(O)=O,myristic_acid,2E1-Substrate
306,CCCCCN(C)N=O,negative,CCCCCN(C)N=O,N_amyl_N_methyl_nitrosamine,2E1-Substrate
307,CCCCCN(CCCCC)N=O,negative,CCCCCN(CCCCC)N=O,NN_diamyl_nitrosoamine,2E1-Substrate
308,CCCCN(CCCC)N=O,negative,CCCCN(CCCC)N=O,NN_dibutyl_nitrosoamine,2E1-Substrate
309,CCCN(CCC)N=O,negative,CCCN(CCC)N=O,NN_dipropyl_nitrosoamine,2E1-Substrate
310,CCCCCCCCC,negative,CCCCCCCCC,nonane,2E1-Substrate
311,CCCCCCCC/C=C\CCCCCCCC(=O)O,negative,CCCCCCCC\C=C/CCCCCCCC(O)=O,oleic_acid,2E1-Substrate
312,CCCCCCCCCCCCCCCC(=O)O,negative,CCCCCCCCCCCCCCCC(O)=O,palmitic_acid,2E1-Substrate
313,C=CCc1ccc2c(c1)OCO2,negative,C=CCC1=CC=C2OCOC2=C1,safrole,2E1-Substrate
314,CCCCCCCCCCCCCCCCCC(=O)O,negative,CCCCCCCCCCCCCCCCCC(O)=O,stearic_acid,2E1-Substrate
315,C=Cc1ccccc1,negative,C=CC1=CC=CC=C1,styrene,2E1-Substrate
316,CCC(C)(C)OC,negative,CCC(C)(C)OC,tert_amyl_methyl_ether,2E1-Substrate
317,CSc1ccc2c(c1)N(CC[C@H]1CCCCN1C)c1ccccc1S2,negative,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1,thioridazine_R,2E1-Substrate
318,Cc1ccccc1,negative,CC1=CC=CC=C1,toluene,2E1-Substrate
319,C/C=C/C,negative,C\C=C\C,trans_2_butene,2E1-Substrate
320,Cc1cccc(C)c1,negative,CC1=CC=CC(=C1)C,xylene_meta,2E1-Substrate
321,Cc1ccccc1C,negative,CC1=CC=CC=C1C,xylene_ortho,2E1-Substrate
322,CC(=O)Oc1ccccc1C(=O)O,negative,CC(=O)OC1=C(C=CC=C1)C(O)=O,Acetylsalicylic Acid,GST-Inducer
323,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,negative,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O,Adriamycin,GST-Substrate
324,CC(C)CCON=O,negative,CC(C)CCON=O,Amyl Nitrite,GST-Substrate
325,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,negative,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,Artemisinin,GST-Inhibitor
326,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,negative,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O,Ascorbic Acid (vit C),GST-Inhibitor
327,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,negative,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1,Betacarotene,GST-Inducer
328,CS(=O)(=O)OCCCCOS(C)(=O)=O,negative,CS(=O)(=O)OCCCCOS(C)(=O)=O,Busulfan,GST-Substrate
329,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,negative,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,Camphora,GST-Inducer
330,O=NN(CCCl)C(=O)NCCCl,negative,ClCCNC(=O)N(CCCl)N=O,Carmustine,GST-Substrate
331,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,negative,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Chenodeoxycholic Acid,GST-Inhibitor
332,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,negative,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C,Chinin,GST-Inhibitor
333,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,negative,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,Chlorambucil,GST-Inducer
334,COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC,negative,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3,Cisapride,GST-Inducer
335,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,negative,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13,Clomipramine,GST-Inhibitor
336,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@H]2CC[C@@H]1N2C,negative,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3,Cocaine,GST-Inducer
337,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,negative,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4,Dicoumarol,GST-Inhibitor
338,CCN(CC)C(=O)N1CCN(C)CC1,negative,CCN(CC)C(=O)N1CCN(C)CC1,Diethylcarbamazine,GST-Inducer
339,CN(C)CCC=C1c2ccccc2COc2ccccc21,negative,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2,Doxepin,GST-Inhibitor
340,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,negative,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl,Etacrynic Acid,GST-Substrate
341,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,negative,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,Finasteride,GST-Inhibitor
342,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,negative,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4,Flunarizine,GST-Inducer
343,C[C@H]1O[C@@H]1P(=O)(O)O,negative,C[C@H]1O[C@@H]1P(O)(O)=O,Fosfomycin,GST-Substrate
344,NCC1(CC(=O)O)CCCCC1,negative,NC[C@@]1(CCCCC1)CC(O)=O,Gabapentin,GST-Inducer
345,CSCCC(NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)O)C(C)O,negative,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,Glucagon,GST-Inhibitor
346,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],negative,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,Glyceryl Trinitrate,GST-Inducer
347,NCC(=O)O,negative,NCC(O)=O,Glycine,GST-Inducer
348,C=CC1=C(C)c2cc3[n-]c(cc4nc(cc5[n-]c(cc1n2)c(C)c5C=C)C(C)=C4CCC(=O)O)c(CCC(=O)O)c3C.O[Fe+2],negative,O[Fe++].CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C=C)C(C)=C([N-]4)C=C5N=C(C=C1[N-]2)C(C)=C5C=C)C(C)=C3CCC(O)=O,Hematin,GST-Inhibitor
349,OO,negative,OO,Hydrogen Peroxide,GST-Inhibitor
350,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1,negative,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O,Ibuprofen,GST-Inducer
351,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,negative,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3,Indometacin,GST-Inhibitor
352,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1,negative,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2,Ketoprofen,GST-Inhibitor
353,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,negative,NC1=NC(N)=C(N=N1)C2=C(Cl)C(Cl)=CC=C2,Lamotrigine,GST-Inducer
354,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](O[C@@H]4[C@@H](O)[C@H](O[C@@H]5[C@@H](O)[C@H](O)O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H]5O)O[C@H](CO)[C@H]4O)O[C@H](CO)[C@H]3O)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,negative,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]5O)[C@H]4O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,Lentinan,GST-Inhibitor
355,c1ccc([C@H]2CN3CCSC3=N2)cc1,negative,C1CN2C[C@@H](N=C2S1)C3=CC=CC=C3,Levamisole,GST-Inducer
356,CC[C@H](C(N)=O)N1CCCC1=O,negative,CC[C@@H](N1CCCC1=O)C(N)=O,Levetiracetam,GST-Inducer
357,N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,negative,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,Melphalan,GST-Substrate
358,COc1ccc(O)cc1,negative,COC1=CC=C(O)C=C1,Mequinol,GST-Inducer
359,NCCS,negative,NCCS,Mercaptamine,GST-Inhibitor
360,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C,negative,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2,Metamizole Sodium,GST-Inducer
361,CSCC[C@H](N)C(=O)O,negative,CSCC[C@H](N)C(O)=O,Methionine,GST-Inducer
362,C[C@@](N)(Cc1ccc(O)c(O)c1)C(=O)O,negative,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O,Methyldopa (levorotatory),GST-Inhibitor
363,N=O,negative,N=O,Nitric Oxide,GST-Inducer
364,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,negative,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3,Olanzapine,GST-Inducer
365,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,Pentoxifylline,GST-Inducer
366,CCC[C@H](N[C@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC,negative,CCC[C@H](N[C@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC,Perindopril,GST-Inhibitor
367,NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,negative,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3,Pipamperone,GST-Inducer
368,CCCCCCNC(=N)NC(=N)N.Cl,negative,Cl.CCCCCCNC(=N)NC(N)=N,Polihexanide,GST-Inhibitor
369,COc1cc(N[C@H](C)CCCN)c2ncccc2c1,negative,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1,Primaquine,GST-Inhibitor
370,CCCc1cc(=O)[nH]c(=S)[nH]1,negative,CCCC1=CC(=O)NC(=S)N1,Propylthiouracil,GST-Inhibitor
371,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,negative,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2,Pyrimethamine,GST-Inhibitor
372,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,negative,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Rofecoxib,GST-Inducer
373,O=N[O-],negative,[O-]N=O,Sodium Nitrite,GST-Inhibitor
374,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc(S(C)=O)cc1,negative,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O,Sulindac,GST-Inducer
375,Nc1c2c(nc3ccccc13)CCCC2,negative,NC1=C2CCCCC2=NC3=C1C=CC=C3,Tacrine,GST-Substrate
376,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,negative,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O,Tadalafil,GST-Inducer
377,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@@H]3C[C@@H]12,negative,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O,Tetracycline,GST-Inhibitor
378,CC[Hg]Sc1ccccc1C(=O)[O-],negative,CC[Hg]SC1=C(C=CC=C1)C([O-])=O,Thiomersal,GST-Inhibitor
379,S=P(N1CC1)(N1CC1)N1CC1,negative,S=P(N1CC1)(N2CC2)N3CC3,Thiotepa,GST-Substrate
380,C[C@@H](C(=O)O)c1ccc(C(=O)c2ccccc2)s1,negative,C[C@@H](C(O)=O)C1=CC=C(S1)C(=O)C2=CC=CC=C2,Tiaprofenic Acid,GST-Inhibitor
381,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,negative,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2,Tienilic Acid,GST-Inhibitor
382,O=C(O)CCCC[C@@H]1CCSS1,negative,OC(=O)CCCC[C@@H]1CCSS1,Tioctic Acid,GST-Inducer
383,COc1ccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,negative,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,Verapamil,GST-Inducer
384,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,negative,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,Adenosine,Sodiumbile_acid_cotransporter-Inducer
385,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,negative,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4,Bosentan,Sodiumbile_acid_cotransporter-Inhibitor
386,CCc1ccc([C@@H](C)CCc2ccc([N+](C)(C)C)cc2)cc1,negative,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C,Colestyramine,Sodiumbile_acid_cotransporter-Inducer
387,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1C=C[C@H](O)C[C@@H](O)CC(=O)O,negative,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O,Rosuvastatin,Sodiumbile_acid_cotransporter-Substrate
388,Nc1ccc(C(=O)O)cc1,negative,NC1=CC=C(C=C1)C(O)=O,Aminobenzoic Acid,SUL-Substrate
389,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,negative,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4,Apomorphine,SUL-Substrate
390,O=C(O)C=Cc1ccccc1,negative,C1=CC=C(C=C1)C=CC(=O)O,Bemiparin,SUL-Substrate
391,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,negative,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Budesonide,SUL-Substrate
392,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,negative,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F,Celecoxib,SUL-Inhibitor
393,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,negative,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,Cholic Acid,SUL-Substrate
394,Oc1c(I)cc(Cl)c2cccnc12,negative,OC1=C(I)C=C(Cl)C2=C1N=CC=C2,Clioquinol,SUL-Inhibitor
395,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,negative,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23,Cortisone,SUL-Inhibitor
396,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,negative,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4,Digitoxin,SUL-Substrate
397,CN[C@@H](C)[C@H](O)c1ccccc1,negative,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,Ephedrin,SUL-Substrate
398,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,negative,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,Galactose,SUL-Substrate
399,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],negative,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2,Minoxidil,SUL-Substrate
400,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,negative,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,Naproxen,SUL-Inhibitor
401,COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,negative,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1,Pantoprazole,SUL-Substrate
402,CN[C@@H](C)[C@@H](O)c1ccccc1,negative,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,Pseudoephedrine,SUL-Substrate
403,Cc1ncc(COP(=O)(O)O)c(C=O)c1O,negative,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1,Pyridoxal Phosphate,SUL-Inhibitor
404,C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1,negative,C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2,Ritodrine,SUL-Substrate
405,O=C(O)CC(O)(CC(=O)O)C(=O)[O-],negative,OC(=O)CC(O)(CC(O)=O)C([O-])=O,Sodium Citrate,SUL-Inhibitor
406,CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,negative,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]5NC(=O)[C@@H](Cc6ccc(Oc7cc4cc(Oc8ccc2cc8Cl)c7O[C@@H]9O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]9NC(=O)C)c(Cl)c6)NC(=O)[C@H](N)c%10ccc(O)c(Oc%11cc(O)cc5c%11)c%10)c%12ccc(O)c(c%12)c%13c(O[C@H]%14O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]%14O)cc(O)cc%13[C@H](NC3=O)C(=O)O,Teicoplanin,SUL-Substrate
407,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,negative,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1,Triclosan,SUL-Inhibitor
408,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,negative,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1,Amiodarone,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
409,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,negative,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
410,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O,negative,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,Bezafibrate,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
411,COCc1c(C(C)C)nc(C(C)C)c(C=C[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1,negative,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C,Cerivastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
412,CC=CC[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,negative,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C,Ciclosporin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
413,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,negative,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4,Digoxin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
414,CCOC(=O)[C@@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,negative,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O,Enalapril,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
415,O=C1[C@@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,negative,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4,Ezetimibe,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
416,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,negative,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,Gemfibrozil,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
417,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C[C@H]2C=Nc3ccccc32)NC[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN3CCN(CC(=O)O)CC(=O)O[In](OC(=O)C3)OC(=O)C2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O,negative,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN3CCN4CCN(CC(O)=O)CC(=O)O[In](OC(=O)C4)OC(=O)C3)C(=O)N[C@H](CN[C@H](C[C@H]5C=NC6=C5C=CC=C6)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)CC7=CC=CC=C7,Indium (111In) Pentetic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
418,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,negative,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4,Lopinavir,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
419,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,negative,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,Lovastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
420,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,negative,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
421,CO[C@H]1C=CO[C@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,negative,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C,Rifamycin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
422,COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O,negative,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O,Silymarin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor
423,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,negative,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,Simvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
424,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,negative,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1,Torasemide,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate
425,CC(=O)OCC[N+](C)(C)C,negative,CC(=O)OCC[N+](C)(C)C,Acetylcholin,Methyltransferase-Inducer
426,CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,negative,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O,Angiotensinamide,Methyltransferase-Inducer
427,C[C@@H]1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1,negative,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2,Argatroban,Methyltransferase-Inducer
428,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,negative,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,Azacitidine,Methyltransferase-Inhibitor
429,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,negative,CN1C=NC(=C1SC2=C3NC=NC3=NC=N2)[N+]([O-])=O,Azathioprine,Methyltransferase-Substrate
430,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,negative,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,Bendroflumethiazide,Methyltransferase-Inhibitor
431,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,negative,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,Captopril,Methyltransferase-Substrate
432,N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,negative,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,Chlorhexidine,Methyltransferase-Inhibitor
433,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,negative,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2,Chlorphenamine,Methyltransferase-Inducer
434,CN(C)CCO,negative,CN(C)CCO,Deanol,Methyltransferase-Substrate
435,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,negative,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,Decitabine,Methyltransferase-Inhibitor
436,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,negative,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2,Dicycloverine,Methyltransferase-Inhibitor
437,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,negative,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O,Diosmin,Methyltransferase-Inhibitor
438,CN(CC(=O)O)C(=N)NP(=O)(O)O,negative,CN(CC(O)=O)C(=N)NP(O)(O)=O,Fosfocreatine,Methyltransferase-Inhibitor
439,NN=c1[nH]ncc2ccccc12,negative,NN=C1NN=CC2=C1C=CC=C2,Hydralazine,Methyltransferase-Inducer
440,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,negative,CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3,Ketotifen,Methyltransferase-Inducer
441,N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,negative,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,Levodopa,Methyltransferase-Substrate
442,CCN(CC)CCC[C@@H](C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,negative,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13,Mepacrine,Methyltransferase-Inhibitor
443,Nc1ccc(O)c(C(=O)O)c1,negative,NC1=CC(C(O)=O)=C(O)C=C1,Mesalazine,Methyltransferase-Inhibitor
444,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,negative,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2,Moclobemide,Methyltransferase-Inhibitor
445,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,negative,OC(=O)C1=CC(=CC=C1O)N=NC2=CC(C(O)=O)=C(O)C=C2,Olsalazine,Methyltransferase-Inhibitor
446,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,negative,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C,Physostigmine,Methyltransferase-Inhibitor
447,CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1,negative,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O,Plicamycin,Methyltransferase-Inhibitor
448,CCN(CC)CCOC(=O)c1ccc(N)cc1,negative,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,Procaine,Methyltransferase-Inhibitor
449,Cc1ncc(CO)c(CO)c1O,negative,CC1=C(O)C(CO)=C(CO)C=N1,Pyridoxine (vit B6),Methyltransferase-Inhibitor
450,[Se],negative,[Se],Selenium Compounds,Methyltransferase-Inhibitor
451,Cn1nnc2c(C(N)=O)ncn2c1=O,negative,CN1N=NC2=C(N=CN2C1=O)C(N)=O,Temozolomide,Methyltransferase-Inhibitor
452,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,negative,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O,Tolcapone,Methyltransferase-Inhibitor
453,COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C,negative,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1,Tubocurarine,Methyltransferase-Inhibitor
454,COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O,negative,COC1=C(OC)C(=O)C(CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C)=C(C)C1=O,Ubidecarenone,Methyltransferase-Substrate
455,c1cnc2cc3c(cc2n1)[C@H]1CNC[C@@H]3C1,negative,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Varenicline,Methyltransferase-Inhibitor
456,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1,negative,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N@@+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6,Vecuronium,Methyltransferase-Inhibitor
457,C[C@@H]1NC(=O)[C@H](NC(=O)c2ncccc2O)[C@H](C)OC(=O)[C@@H](c2ccccc2)NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@H]2CCCN2C1=O,negative,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6,Virginiamycin,Methyltransferase-Inhibitor
458,O=C(CCCCCCC(=O)Nc1ccccc1)NO,negative,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,Vorinostat,Methyltransferase-Inhibitor
459,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,negative,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O,Alfentanil,P450_HFLA-Substrate
460,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,negative,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12,Alprazolam,P450_HFLA-Substrate
461,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@H]1c1ccccc1Cl,negative,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC,Amlodipine,P450_HFLA-Substrate
462,C[C@@H](O[C@@H]1OCCN(Cc2nc(=O)[nH][nH]2)[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,negative,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,Aprepitant,P450_HFLA-Substrate
463,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,negative,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2,Aripiprazole,P450_HFLA-Substrate
464,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,negative,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1,Astemizole,P450_HFLA-Substrate
465,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,negative,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,Atazanavir,P450_HFLA-Inhibitor
466,C[C@H]1[C@H](NC(=O)C(=NOC(C)(C)C(=O)O)c2csc([NH3+])n2)C(=O)N1S(=O)(=O)[O-],negative,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,Aztreonam,P450_HFLA-Substrate
467,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,negative,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4,Buspirone,P450_HFLA-Substrate
468,NC(=O)N1c2ccccc2C=Cc2ccccc21,negative,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3,Carbamazepine,P450_HFLA-Substrate
469,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC,Clarithromycin,P450_HFLA-Substrate
470,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,negative,CN1CCN(CC1)C2=NC3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3,Clotiapine,P450_HFLA-Substrate
471,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,negative,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C,Codeine,P450_HFLA-Substrate
472,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C,negative,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1,Dextropropoxyphene,P450_HFLA-Inducer
473,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,negative,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O,Diltiazem,P450_HFLA-Substrate
474,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,negative,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2,Domperidone,P450_HFLA-Substrate
475,CN(C)CCO[C@@](C)(c1ccccc1)c1ccccn1,negative,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2,Doxylamin,P450_HFLA-Inducer
476,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@@H]13,negative,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14,Eplerenone,P450_HFLA-Substrate
477,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]2O[C@@H](C)C[C@@H](N(C)C)[C@@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Erythromycin,P450_HFLA-Substrate
478,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O,Estriol,P450_HFLA-Substrate
479,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,negative,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C,Ethinylestradiol,P450_HFLA-Substrate
480,CCOc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,negative,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C,Ethylmorphine,P450_HFLA-Substrate
481,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1c1cccc(Cl)c1Cl,negative,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC,Felodipine,P450_HFLA-Substrate
482,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,negative,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Fentanyl,P450_HFLA-Substrate
483,CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,negative,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,Glycyrrhizic Acid,P450_HFLA-Inducer
484,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,negative,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3,Haloperidol,P450_HFLA-Substrate
485,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,negative,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3,Imatinib,P450_HFLA-Substrate
486,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,negative,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5,Indinavir,P450_HFLA-Inhibitor
487,CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,negative,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4,Irinotecan,P450_HFLA-Substrate
488,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)[C@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4,Lercanidipine,P450_HFLA-Substrate
489,O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1,negative,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5,Linopirdine,P450_HFLA-Substrate
490,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,negative,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C,Mibefradil,P450_HFLA-Inhibitor
491,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,negative,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12,Midazolam,P450_HFLA-Inhibitor
492,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,negative,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C,Mifepristone,P450_HFLA-Inhibitor
493,CC(C)[C@H]1CC[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CC1,negative,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O,Nateglinide,P450_HFLA-Substrate
494,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,negative,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4,Nefazodone,P450_HFLA-Inhibitor
495,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,negative,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C,Nelfinavir,P450_HFLA-Inhibitor
496,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,negative,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,Neostigmine,P450_HFLA-Inhibitor
497,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)[C@@H]1c1ccccc1[N+](=O)[O-],negative,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C,Nisoldipine,P450_HFLA-Substrate
498,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@H]1c1cccc([N+](=O)[O-])c1,negative,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC,Nitrendipine,P450_HFLA-Substrate
499,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,negative,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Norethisterone,P450_HFLA-Substrate
500,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,negative,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2,Norfloxacin,P450_HFLA-Inhibitor
501,Cc1ncc([N+](=O)[O-])n1C[C@H](O)CCl,negative,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O,Ornidazole,P450_HFLA-Substrate
502,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=N[C@H]1O,negative,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3,Oxazepam,P450_HFLA-Substrate
503,NNCCc1ccccc1,negative,NNCCC1=CC=CC=C1,Phenelzine,P450_HFLA-Inhibitor
504,Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1,negative,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1,Pleconaril,P450_HFLA-Inducer
505,O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3[C@H]2C1,negative,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4,Praziquantel,P450_HFLA-Substrate
506,CC(C)NC[C@@H](O)COc1cccc2ccccc12,negative,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1,Propranolol,P450_HFLA-Substrate
507,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,negative,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3,Quetiapine,P450_HFLA-Substrate
508,CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C,negative,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O,Rifapentine,P450_HFLA-Inducer
509,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,negative,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1,Risperidone,P450_HFLA-Substrate
510,OCc1cc([C@@H](O)CNCCCCCCOCCCCc2ccccc2)ccc1O,negative,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2,Salmeterol,P450_HFLA-Substrate
511,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,negative,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4,Saquinavir,P450_HFLA-Substrate
512,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C1C,negative,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC,Sirolimus,P450_HFLA-Substrate
513,C=CC[C@@H]1C=C(C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](C(C)=C[C@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,negative,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC,Tacrolimus,P450_HFLA-Substrate
514,CC(C)(C)c1ccc([C@@H](O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,negative,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4,Terfenadine,P450_HFLA-Substrate
515,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,negative,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2,Trazodone,P450_HFLA-Substrate
516,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,negative,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12,Triazolam,P450_HFLA-Substrate
517,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,negative,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,Vincristine,P450_HFLA-Substrate
518,Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1,negative,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2,Zalcitabine,P450_HFLA-Substrate
519,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,negative,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N,Zaleplon,P450_HFLA-Substrate
520,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,negative,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45,Ziprasidone,P450_HFLA-Substrate
521,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,negative,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3,Zolpidem,P450_HFLA-Substrate
522,CCCC(=O)Nc1ccc(OC[C@@H](O)CNC(C)C)c(C(C)=O)c1,negative,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1,Acebutolol,2D6-Inhibitor
523,CCC1C2CC3C4N(C)c5ccccc5C45CC(C2C5O)N3C1O,negative,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6,Ajmaline,2D6-Inhibitor
524,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,negative,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2,Almotriptan,2D6-Substrate
525,C=CCc1ccccc1OC[C@@H](O)CNC(C)C,negative,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C,Alprenolol,2D6-Substrate
526,C[C@@H](N)Cc1ccccc1,negative,C[C@@H](N)CC1=CC=CC=C1,Amfetamine,2D6-Inhibitor
527,NCCCC(=O)O,negative,NCCCC(O)=O,Aminobutyric Acid,2D6-Substrate
528,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,negative,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,Amodiaquine,2D6-Inhibitor
529,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,negative,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3,Amprenavir,2D6-Substrate
530,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,negative,COC1=C(NC2=C3C=CC=CC3=NC4=CC=CC=C24)C=CC(NS(C)(=O)=O)=C1,Amsacrine,2D6-Substrate
531,CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1,negative,CCN(CC)CCCN([C@H]1CC2=CC=CC=C2C1)C3=CC=CC=C3,Aprindine,2D6-Substrate
532,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3,negative,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,Artemether,2D6-Substrate
533,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,negative,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2,Atomoxetine,2D6-Inhibitor
534,COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4,Barnidipine,2D6-Inhibitor
535,CC(=O)c1cc2cccc(OC[C@H](O)CNC(C)C)c2o1,negative,CC(C)NC[C@@H](O)COC1=CC=CC2=C1OC(=C2)C(C)=O,Befunolol,2D6-Substrate
536,COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4,Benidipine,2D6-Inhibitor
537,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,negative,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Benzatropine,2D6-Substrate
538,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1,negative,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1,Benzethonium,2D6-Substrate
539,CC(C)COC[C@H](CN(Cc1ccccc1)c1ccccc1)N1CCCC1,negative,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3,Bepridil,2D6-Substrate
540,CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,negative,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1,Betaxolol,2D6-Substrate
541,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,negative,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F,Bicalutamide,2D6-Inhibitor
542,O[C@@](CCN1CCCCC1)(c1ccccc1)[C@@H]1C[C@@H]2C=C[C@H]1C2,negative,O[C@](CCN1CCCCC1)([C@@H]2C[C@H]3C[C@@H]2C=C3)C4=CC=CC=C4,Biperiden,2D6-Inhibitor
543,CC(C)NC[C@@H](O)COc1ccc(COCCOC(C)C)cc1,negative,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1,Bisoprolol,2D6-Substrate
544,CC(C)C[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,negative,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O,Bortezomib,2D6-Inhibitor
545,CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1,negative,CC(C)(C)N1CC[C@](CC1)(C2=CC=CC=C2)C3=CC=CC=C3,Budipine,2D6-Inhibitor
546,COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1,negative,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1,Buflomedil,2D6-Substrate
547,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,negative,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C,Bupivacaine,2D6-Substrate
548,Cc1ccc(Cl)c(OC[C@@H](O)CNC(C)(C)C)c1,negative,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1,Bupranolol,2D6-Substrate
549,CC(C)(C)NC[C@H](O)COc1cccc2c1CCC(=O)N2,negative,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2,Carteolol,2D6-Inhibitor
550,CC1O[C@@]2(CS1)CN1CCC2CC1,negative,CC1O[C@@]2(CS1)CN1CCC2CC1,Cevimeline,2D6-Substrate
551,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,negative,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1,Chlordiazepoxide,2D6-Substrate
552,c1ccc(C2(c3ccccc3)C[C@H]2C2=NCCN2)cc1,negative,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4,Cibenzoline,2D6-Substrate
553,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,negative,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2,Cilostazol,2D6-Substrate
554,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,negative,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,Cinacalcet,2D6-Substrate
555,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,negative,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3,Clemastine,2D6-Inhibitor
556,C=C1CC[C@H](O)CC1=CC=C1CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,negative,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C,Colecalciferol,2D6-Inhibitor
557,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,negative,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3,Cyclobenzaprine,2D6-Substrate
558,N=C(N)N1CCc2ccccc2C1,negative,NC(=N)N1CCC2=C(C1)C=CC=C2,Debrisoquine,2D6-Substrate
559,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,negative,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3,Delavirdine,2D6-Inhibitor
560,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,negative,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4,Desloratadine,2D6-Inhibitor
561,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,negative,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Desvenlafaxine,2D6-Substrate
562,C[C@H](N)Cc1ccccc1,negative,C[C@H](N)CC1=CC=CC=C1,Dexamfetamine,2D6-Inhibitor
563,Cc1cccc([C@H](C)c2c[nH]cn2)c1C,negative,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,Dexmedetomidine,2D6-Inhibitor
564,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,negative,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C,Dihydrocodeine,2D6-Substrate
565,CS(C)=O,negative,CS(C)=O,Dimethyl Sulfoxide,2D6-Inhibitor
566,CN(C)CCOC(c1ccccc1)c1ccccc1,negative,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Diphenhydramin,2D6-Substrate
567,O=C(O[C@@H]1C[C@@H]2C[C@@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,negative,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45,Dolasetron,2D6-Substrate
568,COc1cc2c(cc1OC)C(=O)[C@H](CC1CCN(Cc3ccccc3)CC1)C2,negative,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1,Donepezil,2D6-Substrate
569,COc1cc2nc(N3CCN(C(=O)[C@@H]4COc5ccccc5O4)CC3)nc(N)c2cc1OC,negative,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5,Doxazosin,2D6-Substrate
570,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,negative,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Duloxetine,2D6-Substrate
571,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,negative,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3,Efavirenz,2D6-Inhibitor
572,CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,negative,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3,Eletriptan,2D6-Substrate
573,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,negative,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5,Emetine,2D6-Substrate
574,COc1ccc(C(=O)Nc2ccccc2[C@H](C)CN2CCCCC2)cc1,negative,COC1=CC=C(C=C1)C(=O)NC2=C(C=CC=C2)[C@H](C)CN3CCCCC3,Encainide,2D6-Substrate
575,NC1=NC[C@@H]2c3ccccc3Cc3ccccc3N12,negative,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3,Epinastine,2D6-Inhibitor
576,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,negative,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3,Escitalopram,2D6-Substrate
577,CCN[C@@H](C)Cc1ccccc1,negative,CCN[C@@H](C)CC1=CC=CC=C1,Etilamfetamine,2D6-Substrate
578,CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1,negative,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,Fesoterodine,2D6-Substrate
579,CC(C)(C(=O)O)c1ccc([C@@H](O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,negative,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4,Fexofenadine,2D6-Inhibitor
580,O=C(NC[C@@H]1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,negative,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1,Flecainide,2D6-Substrate
581,COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1,negative,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1,Formoterol,2D6-Substrate
582,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,negative,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24,Galantamine,2D6-Substrate
583,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,negative,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4,Gefitinib,2D6-Inhibitor
584,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,negative,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1,Gepirone,2D6-Substrate
585,CN1[C@H]2CCC[C@@H]1C[C@@H](NC(=O)c1nn(C)c3ccccc13)C2,negative,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4,Granisetron,2D6-Substrate
586,N=C(N)NC[C@H]1COc2ccccc2O1,negative,NC(=N)NC[C@H]1COC2=C(O1)C=CC=C2,Guanoxan,2D6-Substrate
587,CCCCN(CCCC)CC[C@H](O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,negative,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F,Halofantrine,2D6-Inhibitor
588,Cl,negative,Cl,Hydrochloric Acid,2D6-Inhibitor
589,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,negative,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C,Hydrocodone,2D6-Substrate
590,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5,negative,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O,Hydromorphone,2D6-Substrate
591,CCN(CCO)CCC[C@@H](C)Nc1ccnc2cc(Cl)ccc12,negative,CCN(CCO)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2,Hydroxychloroquine,2D6-Inhibitor
592,OCCOCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,negative,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3,Hydroxyzine,2D6-Inhibitor
593,CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,negative,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O,Idarubicin,2D6-Inhibitor
594,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,negative,O=C(N[C@H]1CCN(CC1)CCC2=CNC3=C2C=CC=C3)C4=CC=CC=C4,Indoramin,2D6-Substrate
595,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,negative,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5,Irbesartan,2D6-Inhibitor
596,C[C@@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1,negative,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O,Labetalol,2D6-Inhibitor
597,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,negative,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34,Lisuride,2D6-Substrate
598,CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1,negative,CN(CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2)CC(=O)C4=CC=C(Cl)C=C4,Lofepramine,2D6-Substrate
599,O=NN(CCCl)C(=O)NC1CCCCC1,negative,ClCCN(N=O)C(=O)N[C@H]1CCCCC1,Lomustine,2D6-Substrate
600,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,negative,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4,Loperamide,2D6-Substrate
601,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,negative,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3,Loratadine,2D6-Inhibitor
602,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5,Manidipine,2D6-Inhibitor
603,CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12,negative,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4,Maprotiline,2D6-Substrate
604,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,negative,C[C@H]1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,Melperone,2D6-Inhibitor
605,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2,negative,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2,Memantine,2D6-Inhibitor
606,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,negative,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1,Mepyramine,2D6-Inhibitor
607,c1ccc2c(c1)Sc1ccccc1N2C[C@H]1CN2CCC1CC2,negative,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4,Mequitazine,2D6-Substrate
608,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,negative,CN1CCCC[C@H]1CCN2C3=C(SC4=C2C=C(C=C4)S(C)=O)C=CC=C3,Mesoridazine,2D6-Substrate
609,CN[C@@H](C)Cc1ccccc1,negative,CN[C@@H](C)CC1=CC=CC=C1,Metamfetamine,2D6-Substrate
610,CN[C@@H](C)Cc1ccccc1OC,negative,CN[C@@H](C)CC1=C(OC)C=CC=C1,Methoxyphenamine,2D6-Substrate
611,CCC1(CC)C(=O)NC[C@@H](C)C1=O,negative,CCC1(CC)C(=O)NC[C@@H](C)C1=O,Methyprylon,2D6-Substrate
612,COCCc1ccc(OC[C@H](O)CNC(C)C)cc1,negative,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1,Metoprolol,2D6-Substrate
613,CN1CCN2c3ccccc3Cc3ccccc3[C@H]2C1,negative,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3,Mianserin,2D6-Substrate
614,COc1ccc(OC)c([C@H](O)CNC(=O)CN)c1,negative,COC1=CC([C@H](O)CNC(=O)CN)=C(OC)C=C1,Midodrine,2D6-Inhibitor
615,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,negative,CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3,Minaprine,2D6-Substrate
616,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1,negative,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3,Mirtazapine,2D6-Inhibitor
617,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,negative,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O,Morphine,2D6-Substrate
618,O[C@@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1,negative,O[C@@H](CNC[C@@H](O)[C@@H]1CCC2=C(O1)C=CC(F)=C2)[C@H]3CCC4=CC(F)=CC=C4O3,Nebivolol,2D6-Substrate
619,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,negative,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4,Nevirapine,2D6-Substrate
620,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,negative,CO[C@]12C[C@@H](COC(=O)C3=CC(Br)=CN=C3)CN(C)[C@@H]1CC4=CN(C)C5=CC=CC2=C45,Nicergoline,2D6-Substrate
621,O=C(O)c1cccnc1,negative,OC(=O)C1=CC=CN=C1,Nicotinic Acid,2D6-Inhibitor
622,NC(=O)NN=Cc1ccc([N+](=O)[O-])o1,negative,NC(=O)NN=CC1=CC=C(O1)[N+]([O-])=O,Nitrofural,2D6-Substrate
623,NC[C@H](O)c1ccc(O)cc1,negative,NC[C@H](O)C1=CC=C(O)C=C1,Octopamine,2D6-Substrate
624,OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1,negative,OCCN1CCN(CCCN2C3=C(C=CC=C3)C=CC4=C2C=CC=C4)CC1,Opipramol,2D6-Substrate
625,Cc1ccccc1[C@H](OCCN(C)C)c1ccccc1,negative,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2,Orphenadrine (citrate),2D6-Inhibitor
626,CC(C)NC[C@H]1CCc2cc(CO)c([N+](=O)[O-])cc2N1,negative,CC(C)NC[C@H]1CCC2=C(N1)C=C(C(CO)=C2)[N+]([O-])=O,Oxamniquine,2D6-Inhibitor
627,Cc1ccnc(NC(=O)[C@H](C)c2cccc(C(=O)c3ccccc3)c2)c1,negative,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3,Oxatomide,2D6-Inhibitor
628,C=CCOc1ccccc1OC[C@H](O)CNC(C)C,negative,CC(C)NC[C@@H](O)COC1=C(OCC=C)C=CC=C1,Oxprenolol,2D6-Inhibitor
629,CCN(CC)CC#CCOC(=O)[C@@](O)(c1ccccc1)C1CCCCC1,negative,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2,Oxybutynin,2D6-Inhibitor
630,O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,negative,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2,Palonosetron,2D6-Substrate
631,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1,negative,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3,Parecoxib,2D6-Inhibitor
632,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,negative,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3,Paroxetine,2D6-Inhibitor
633,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,negative,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,Pentamidine Isethionate,2D6-Substrate
634,CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1,negative,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2,Pentoxyverine,2D6-Substrate
635,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,negative,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34,Pergolide,2D6-Inhibitor
636,C1CCC(C(C[C@H]2CCCCN2)C2CCCCC2)CC1,negative,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3,Perhexiline,2D6-Substrate
637,N=C(N)NC(=N)NCCc1ccccc1,negative,NC(=N)NC(=N)NCCC1=CC=CC=C1,Phenformin,2D6-Substrate
638,CC(C)(N)Cc1ccccc1,negative,CC(C)(N)CC1=CC=CC=C1,Phentermine,2D6-Inhibitor
639,CC(C)NC[C@@H](O)COc1cccc2[nH]ccc12,negative,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2,Pindolol,2D6-Substrate
640,CCc1ccc(CCOc2ccc(C[C@@H]3SC(=O)NC3=O)cc2)nc1,negative,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1,Pioglitazone,2D6-Inhibitor
641,C1CNCCN1,negative,C1CNCCN1,Piperazine,2D6-Substrate
642,CCC[N@@+]12[C@H]3C[C@@]45c6ccccc6N(C)[C@H]4[C@@H]1C[C@H]([C@@H]3[C@H]5O)[C@H](CC)[C@H]2O,negative,CCC[N@+]12[C@H](O)[C@@H](CC)[C@@H]3C[C@H]1[C@@H]4N(C)C5=C(C=CC=C5)[C@]46C[C@H]2[C@H]3[C@H]6O,Prajmaline,2D6-Substrate
643,CCN(CC)CCNC(=O)c1ccc(N)cc1,negative,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,Procainamide,2D6-Substrate
644,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,negative,CN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1,Prochlorperazine,2D6-Substrate
645,C[C@@H](CN1c2ccccc2Sc2ccccc21)N(C)C,negative,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C,Promethazine,2D6-Inhibitor
646,CCCNC[C@@H](O)COc1ccccc1C(=O)CCc1ccccc1,negative,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2,Propafenone,2D6-Inhibitor
647,CNCCCC1c2ccccc2C=Cc2ccccc21,negative,CNCCC[C@H]1C2=C(C=CC=C2)C=CC3=C1C=CC=C3,Protriptyline,2D6-Substrate
648,CN1CCCN=C1C=Cc1cccs1,negative,CN1CCCN=C1C=CC2=CC=CS2,Pyrantel,2D6-Substrate
649,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,negative,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O,Ranitidine,2D6-Substrate
650,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1,negative,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,Reboxetine,2D6-Inducer
651,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,negative,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC,Remoxipride,2D6-Substrate
652,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,negative,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,Rivastigmine,2D6-Inhibitor
653,CCCN(CCC)CCc1cccc2c1CC(=O)N2,negative,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2,Ropinirole,2D6-Inhibitor
654,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,negative,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C,Ropivacaine,2D6-Substrate
655,CN(CCOc1ccc(C[C@@H]2SC(=O)NC2=O)cc1)c1ccccn1,negative,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3,Rosiglitazone,2D6-Inhibitor
656,O=C(CO)NCCCOc1cccc(CN2CCCCC2)c1,negative,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1,Roxatidine,2D6-Substrate
657,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,negative,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,Rutoside,2D6-Inhibitor
658,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,negative,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25,Sertindole,2D6-Substrate
659,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,negative,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3,Sertraline,2D6-Inhibitor
660,C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@H](C(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@@H]([C@H](C)O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]([C@H](C)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O,negative,C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H](CC6=CC=CC=C6)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O,Somatostatin,2D6-Inhibitor
661,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1,negative,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1,Sparteine,2D6-Inhibitor
662,Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,negative,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3,Sulfaphenazole,2D6-Inhibitor
663,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,negative,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1,Tamsulosin,2D6-Substrate
664,COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,negative,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2,Tetrabenazine,2D6-Inhibitor
665,COc1ccc2c3c1O[C@H]1C(OC(C)=O)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341,negative,COC1=CC=C2C[C@@H]3[C@H]4CC=C(OC(C)=O)[C@@H]5OC1=C2[C@]45CCN3C,Thebacon,2D6-Substrate
666,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,negative,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2,Timolol,2D6-Substrate
667,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,negative,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1,Tiotixene,2D6-Inhibitor
668,C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21,negative,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5,Tiotropium Bromide,2D6-Substrate
669,Cc1ccc(C(=O)[C@H](C)CN2CCCCC2)cc1,negative,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2,Tolperisone,2D6-Substrate
670,Cc1ccc(O)c([C@@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,negative,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C,Tolterodine,2D6-Substrate
671,COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1,negative,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C,Tramadol,2D6-Inhibitor
672,O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1,negative,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC(=CC=C3)C(F)(F)F,Trifluperidol,2D6-Substrate
673,C[C@H](CN(C)C)CN1c2ccccc2CCc2ccccc21,negative,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,Trimipramine,2D6-Substrate
674,CN(C)CCN(Cc1ccccc1)c1ccccn1,negative,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,Tripelennamine,2D6-Inhibitor
675,Cc1ccc(C(=CCN2CCCC2)c2ccccn2)cc1,negative,CC1=CC=C(C=C1)C(=C/CN2CCCC2)C3=CC=CC=N3,Triprolidine,2D6-Inhibitor
676,CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2,negative,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4,Tropisetron,2D6-Substrate
677,COc1ccc([C@@H](CN(C)C)C2(O)CCCCC2)cc1,negative,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2,Venlafaxine,2D6-Inhibitor
678,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC,negative,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1,Vernakalant,2D6-Substrate
679,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,negative,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,Vinblastine,2D6-Substrate
680,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,negative,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC,Vinorelbine,2D6-Substrate
681,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21,negative,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12,Yohimbin,2D6-Inhibitor
682,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,negative,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3,Zotepine,2D6-Substrate
683,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(Cl)cc32)CC1,negative,OCCN1CCN(CCC=C2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1,Zuclopenthixol,2D6-Substrate
684,c1cnc(N2CCNCC2)nc1,negative,C1CN(CCN1)C2=NC=CC=N2,1_PP,2D6-Substrate
685,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C=O)C[C@@H]21,negative,CCCCCC1=CC2=C([C@@H]3CC(=CC[C@H]3C(C)(C)O2)C=O)C(=C1)O,11_oxo_delta_8_tetrahydro_cannabinol,2D6-Substrate
686,CCC1CC2CC3c4[nH]c5ccc(OC)cc5c4CCN(C2)C13,negative,CCC1CC2CC3C1N(CCC4=C3[NH]C5=C4C=C(OC)C=C5)C2,12_methoxy_ibogamine,2D6-Substrate
687,O=C1C=C2CN(Cc3ccccc3Cl)CCC2S1,negative,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2,2_oxo_ticlopidine,2D6-Substrate
688,CCCCNC(C)Cc1ccc(OC)cc1,negative,CCCCNC(C)CC1=CC=C(OC)C=C1,4_methoxy_N_butylamphetamine,2D6-Substrate
689,CC(N)Cc1ccccc1,negative,CC(N)CC1=CC=CC=C1,amphetamine,2D6-Substrate
690,COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)NC(=C([C@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4)C,barnidipine,2D6-Substrate
691,CCC(N)Cc1ccc2c(c1)OCO2,negative,CCC(N)CC1=CC=C2OCOC2=C1,BDB,2D6-Substrate
692,Cc1cc(NC(=O)NC(=O)c2ccccc2N(C)C)ccc1Oc1ncc(Br)cn1,negative,CN(C)C1=CC=CC=C1C(=O)NC(=O)NC2=CC=C(OC3=NC=C(Br)C=N3)C(=C2)C,benzoyl_phenyl_urea,2D6-Substrate
693,O=c1ccc2nc3ccc(OCc4ccccc4)cc3oc-2c1,negative,O=[C]1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1,benzyl_oxy_resorufin,2D6-Substrate
694,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,negative,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O,bortezomib,2D6-Substrate
695,CCc1cccc2cc([C@H](O)CNC(C)(C)C)oc12,negative,CCC1=C2OC(=CC2=CC=C1)[C@H](O)CNC(C)(C)C,bufuralol_R,2D6-Substrate
696,CCCCN1CCCC[C@@H]1C(=O)Nc1c(C)cccc1C,negative,CCCCN1CCCC[C@@H]1C(=O)NC2=C(C)C=CC=C2C,bupivacaine_R,2D6-Substrate
697,CNC(=O)Oc1cccc2c1OC(C)(C)C2,negative,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1,carbofuran,2D6-Substrate
698,COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12,negative,COC1=CC=CC=C1OCCNC[C@H](O)COC2=C3C(=CC=C2)[NH]C4=C3C=CC=C4,carvedilol_S,2D6-Substrate
699,COc1ccc(C(c2ccc(O)c(O)c2)C(Cl)(Cl)Cl)cc1,negative,COC1=CC=C(C=C1)C(C2=CC=C(O)C(=C2)O)C(Cl)(Cl)Cl,catechol_methoxychlor,2D6-Substrate
700,CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl,negative,CCO[P](=S)(OCC)OC1=NC(=C(Cl)C=C1Cl)Cl,chlorpyrifos,2D6-Substrate
701,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,negative,C1CN(CCN1C\C=C\C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4,cinnarizine,2D6-Substrate
702,COc1ccc([C@H](CC(=O)O)N2CCN(CCCc3ccc4c(n3)NCCC4)C2=O)cn1,negative,COC1=NC=C(C=C1)[C@H](CC(O)=O)N2CCN(CCCC3=NC4=C(CCCN4)C=C3)C2=O,compound_A,2D6-Substrate
703,COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1,negative,COC1=C(CN[C@H]2CCCN[C@H]2C3=CC=CC=C3)C=C(OC(F)(F)F)C=C1,cp_122_721,2D6-Substrate
704,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,negative,COC1=CC(=CC=C1O)\C=C\C(=O)CC(=O)\C=C\C2=CC=C(O)C(=C2)OC,curcumin,2D6-Substrate
705,CC1=CC[C@H]2[C@@H](C1)C2(C)C,negative,CC1=CC[C@H]2[C@H](C2(C)C)C1,delta_3_carene,2D6-Substrate
706,O=C1OC2(c3ccc(OCc4ccccc4)cc3Oc3cc(OCc4ccccc4)ccc32)c2ccccc21,negative,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17,dibenzyl_fluorescein,2D6-Substrate
707,Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,negative,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C)C=C4,dimemorfan,2D6-Substrate
708,CCOP(=S)(OCC)SCCSCC,negative,CCO[P](=S)(OCC)SCCSCC,disulfoton,2D6-Substrate
709,COc1cc2c(CCN3CCN(c4cccc(Cl)c4C)CC3)nn(Cc3c[nH]cn3)c2cc1OC,negative,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl,DY_9760e,2D6-Substrate
710,Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12,negative,CC1=C2[NH]C3=CC=CC=C3C2=C(C)C4=CN=CC=C14,ellipticine,2D6-Substrate
711,C=C(C)c1ccc(OC)c(CN[C@H]2C3CCN(CC3)[C@H]2C(c2ccccc2)c2ccccc2)c1,negative,COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)=C,ezlopitant_alkene_CJ_12_458,2D6-Substrate
712,CC(C)n1c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,negative,CC(C)[N]1C2=CC=CC=C2C(=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3,fluvastatin,2D6-Substrate
713,COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1,negative,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,fluvoxamine,2D6-Substrate
714,COc1ccc2[nH]cc(CCN(C(C)C)C(C)C)c2c1,negative,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1,foxy,2D6-Substrate
715,COc1ccc2c3c([nH]c2c1)C(C)=NCC3,negative,COC1=CC2=C(C=C1)C3=C([NH]2)C(=NCC3)C,harmaline,2D6-Substrate
716,COc1ccc2c(c1)[nH]c1c(C)nccc12,negative,COC1=CC=C2C(=C1)[NH]C3=C2C=CN=C3C,harmine,2D6-Substrate
717,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,negative,COC1=CC(=CC=C1OCCCN2CCC(CC2)C3=NOC4=CC(=CC=C34)F)C(C)=O,iloperidone,2D6-Substrate
718,COc1ccc2c(c1)c(CC(=O)NCCc1ccccc1)c(C)n2C(=O)c1ccc(Cl)cc1,negative,COC1=CC=C2[N](C(=C(CC(=O)NCCC3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4,indomethacin_phenethylamide,2D6-Substrate
719,CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O)n2C1,negative,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O,licofelone,2D6-Substrate
720,C=CC(C)(O)CCC=C(C)C,negative,CC(C)=CCCC(C)(O)C=C,linalool,2D6-Substrate
721,CCn1nnc(C2=CCCN(C)C2)n1,negative,CC[N]1N=NC(=N1)C2=CCCN(C)C2,LU_2509,2D6-Substrate
722,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,negative,CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C,Lu_AA21004,2D6-Substrate
723,CC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1,negative,CC(N1CCCC1)C(=O)C2=CC=C3OCOC3=C2,MDPPP,2D6-Substrate
724,CC[N+](C)(CC)CCc1c(C(F)(F)F)c2ccc(OC)cc2oc1=O,negative,CC[N+](C)(CC)CCC1=C(C2=CC=C(OC)C=C2O[C]1=O)C(F)(F)F,MeAMFC,2D6-Substrate
725,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,negative,CCOC(=O)C1(CCN(C)CC1)C2=CC=CC=C2,meperidine,2D6-Substrate
726,c1ccc2c(c1)Sc1ccccc1N2C[C@@H]1CN2CCC1CC2,negative,C1CN2CCC1[C@@H](C2)CN3C4=CC=CC=C4SC5=CC=CC=C35,mequitazine,2D6-Substrate
727,CCC(=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1,negative,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,methadone_R,2D6-Substrate
728,CNC(=S)Oc1cc(C)c(SC)c(C)c1,negative,CNC(=S)OC1=CC(=C(SC)C(=C1)C)C,methiocarb,2D6-Substrate
729,CN1CCN2c3ccccc3Cc3ccccc3[C@@H]2C1,negative,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CC=C24,mianserin_R,2D6-Substrate
730,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,negative,CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)SC4=CC=C(NC(=O)C5CC5)C=C4,MK_0457_tozasertib,2D6-Substrate
731,CSc1nc(-c2ccnc(NC(C)c3ccccc3)c2)c(-c2ccc(F)cc2)[nH]1,negative,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4,ML_3403,2D6-Substrate
732,COc1ccc2c(C[n+]3ccccc3)cc(=O)oc2c1,negative,COC1=CC2=C(C=C1)C(=C[C](=O)O2)C[N+]3=CC=CC=C3,MMPyrC,2D6-Substrate
733,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,negative,CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC2(CC2)CC(O)=O)C3=CC=CC(=C3)\C=C\C4=CC=C5C=CC(=CC5=N4)Cl,montelukast,2D6-Substrate
734,CCC(C(=O)c1ccc(C)cc1)N1CCCC1,negative,CCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2,MPBP,2D6-Substrate
735,CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1,negative,CCCN(CCC)CCC1=CC=C(OC)C(=C1)OCCC2=CC=CC=C2,NE_100,2D6-Substrate
736,CN1CCCC1c1cccnc1,negative,CN1CCCC1C2=CC=CN=C2,nicotine,2D6-Substrate
737,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(c1ccccc1)c1ccccc1,negative,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2,norLAAM,2D6-Substrate
738,Cc1nccn1C[C@@H]1CCc2c(c3ccccc3n2C)C1=O,negative,C[N]1C2=C(C(=O)[C@@H](CC2)C[N]3C=CN=C3C)C4=CC=CC=C14,ondansetron,2D6-Substrate
739,CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1,negative,CCCN1CCC[C@H](C1)C2=CC(=CC=C2)[S](C)(=O)=O,OSU_6162,2D6-Substrate
740,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,negative,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,perhexiline,2D6-Substrate
741,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,negative,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,pregnenolone,2D6-Substrate
742,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,negative,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,progesterone,2D6-Substrate
743,O=C1C=C2CN(C(C(=O)C3CC3)c3ccccc3F)CCC2S1,negative,FC1=CC=CC=C1C(N2CCC3SC(=O)C=C3C2)C(=O)C4CC4,R_95913,2D6-Substrate
744,CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,negative,CN\C(NCCSCC1=CC=C(CN(C)C)O1)=C/[N](=O)=O,ranitidine,2D6-Substrate
745,OCCCOc1cccc(CN2CCCCC2)c1,negative,OCCCOC1=CC=CC(=C1)CN2CCCCC2,roxatidine_m5,2D6-Substrate
746,C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1,negative,C[C@@H]1O[C@@]2(CS1)CN3CCC2CC3,SNI_2011_R_R,2D6-Substrate
747,CCCSP(=S)(OCC)Oc1ccc(SC)cc1,negative,CCCS[P](=S)(OCC)OC1=CC=C(SC)C=C1,sulprofos,2D6-Substrate
748,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O,negative,CN(C)[S](=O)(=O)CCNC(=O)N(CCCl)N=O,tauromustine,2D6-Substrate
749,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@](C)(CC[C@@]4(O)C(C)(C)C=CC(=O)[C@@]42C)O3)cc2c1OCO2,negative,COC1=CC(=CC2=C1OCO2)C3=CC4=C(C[C@]5(O)[C@](C)(CC[C@@]6(O)C(C)(C)C=CC(=O)[C@]56C)O4)[C](=O)O3,territrem_A,2D6-Substrate
750,CC(NCC(O)COc1cccc2ccccc12)C(C)(C)C,negative,CC(NCC(O)COC1=CC=CC2=CC=CC=C12)C(C)(C)C,tert_butyl_propranolol,2D6-Substrate
751,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,negative,CC(C)N(CC[C@H](C1=CC=CC=C1)C2=CC(=CC=C2O)C)C(C)C,tolterodine,2D6-Substrate
752,C(=C/c1ccccc1)\c1ccccc1,negative,C1=CC=C(C=C1)\C=C\C2=CC=CC=C2,trans_stilbene,2D6-Substrate
753,CN1C2CC[C@H]1CC(OC(=O)c1c[nH]c3ccccc13)C2,negative,CN1[C@H]2CCC1CC(C2)OC(=O)C3=C[NH]C4=CC=CC=C34,tropisetron,2D6-Substrate
754,CCNc1ncn(Cc2ccc(OC)c(OC3CCCC3)c2)c2nc(C(C)C)nc1-2,negative,CCNC1=C2N=C(N=C2[N](CC3=CC=C(OC)C(=C3)OC4CCCC4)C=N1)C(C)C,V_11294,2D6-Substrate
755,COc1ccc([C@H](CN(C)C)C2(O)CCCCC2)cc1,negative,COC1=CC=C(C=C1)[C@H](CN(C)C)C2(O)CCCCC2,venlafaxine_R,2D6-Substrate
756,COCC[C@H]1CC2CN3CCc4c([nH]c5ccccc45)[C@](C(=O)OC)(C2)C13,negative,COCC[C@H]1CC2CN3CCC4=C([NH]C5=CC=CC=C45)[C@](C2)(C13)C(=O)OC,18_methoxy_coronaridine,2D6-Substrate
757,COc1ccc2c(c1)c(CC(=O)NCC(O)c1ccccc1)c(C)n2C(=O)c1ccc(Cl)cc1,negative,COC1=CC=C2[N](C(=C(CC(=O)NCC(O)C3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4,2_hydroxy_indomethacin_phenethylamide,2D6-Substrate
758,COC(=O)[C@H](c1ccccc1Cl)N1CCC2SC(=O)C=C2C1,negative,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3,2_oxo_clopidogrel,2D6-Substrate
759,COc1ccc(CC(C)N)cc1,negative,COC1=CC=C(CC(C)N)C=C1,4_methoxy_amphetamine,2D6-Substrate
760,CCNC(C)Cc1ccc(OC)cc1,negative,CCNC(C)CC1=CC=C(OC)C=C1,4_methoxy_N_ethylamphetamine,2D6-Substrate
761,CC(NC(N)=O)c1cc2ccccc2s1,negative,CC(NC(N)=O)C1=CC2=CC=CC=C2S1,ABT_66193,2D6-Substrate
762,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,negative,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C,all_trans_retinal,2D6-Substrate
763,CC[N+](C)(CC)CCc1c(C)c2ccc(OC)cc2oc1=O,negative,CC[N+](C)(CC)CCC1=C(C)C2=CC=C(OC)C=C2O[C]1=O,AMMC,2D6-Substrate
764,CCCCNCc1cc(=O)oc2cc(OC)ccc12,negative,CCCCNCC1=C[C](=O)OC2=CC(=CC=C12)OC,BMAMC,2D6-Substrate
765,CC(C)NCCCOc1cccc2ccccc12,negative,CC(C)NCCCOC1=CC=CC2=CC=CC=C12,deshydroxy_propranolol,2D6-Substrate
766,CC(NCCCOc1cccc2ccccc12)C(F)(F)F,negative,CC(NCCCOC1=CC=CC2=CC=CC=C12)C(F)(F)F,deshydroxy_trifluoro_propranolol,2D6-Substrate
767,CNCCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,negative,CNCCCC1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3,desmethyl_citalopram,2D6-Substrate
768,CC(NCC(O)COc1cccc2ccccc12)C(F)F,negative,CC(NCC(O)COC1=CC=CC2=CC=CC=C12)C(F)F,difluoro_propranolol,2D6-Substrate
769,COc1ccc2c(CN(C)C)cc(=O)oc2c1,negative,COC1=CC=C2C(=C[C](=O)OC2=C1)CN(C)C,DiMMAMC,2D6-Substrate
770,CCNCc1cc(=O)oc2cc(OC)ccc12,negative,CCNCC1=C[C](=O)OC2=CC(=CC=C12)OC,EMAMC,2D6-Substrate
771,COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1,negative,COC1=C(CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C=C(C=C1)C(C)C,ezlopitant,2D6-Substrate
772,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,negative,FC1=CC=C(C=C1)C(N2CCN(CC2)C\C=C\C3=CC=CC=C3)C4=CC=C(F)C=C4,flunarizine,2D6-Substrate
773,CC(CF)NCC(O)COc1cccc2ccccc12,negative,CC(CF)NCC(O)COC1=CC=CC2=CC=CC=C12,fluoro_propranolol,2D6-Substrate
774,CC(C)C(C)NCC(O)COc1cccc2ccccc12,negative,CC(C)C(C)NCC(O)COC1=CC=CC2=CC=CC=C12,isopropyl_propranolol,2D6-Substrate
775,COc1ccc2c(CN)cc(=O)oc2c1,negative,COC1=CC=C2C(=C[C](=O)OC2=C1)CN,MAMC,2D6-Substrate
776,CC[C@H](Cc1ccc2c(c1)OCO2)NC,negative,CC[C@H](CC1=CC=C2OCOC2=C1)NC,MBDB,2D6-Substrate
777,CC(N)Cc1ccc2c(c1)OCO2,negative,CC(N)CC1=CC=C2OCOC2=C1,MDA_tenamfetamine,2D6-Substrate
778,CN[C@H](C)Cc1ccc2c(c1)OCO2,negative,CN[C@H](C)CC1=CC=C2OCOC2=C1,MDMA_R,2D6-Substrate
779,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,negative,CN1CCCCC1CCN2C3=CC=CC=C3SC4=CC=C(C=C24)[S](C)=O,mesoridazine,2D6-Substrate
780,CN[C@H](C)Cc1ccccc1,negative,CN[C@H](C)CC1=CC=CC=C1,methamphetamine_R,2D6-Substrate
781,C=CCc1ccc(OC)c(OC)c1,negative,COC1=C(OC)C=C(CC=C)C=C1,methyl_eugenol,2D6-Substrate
782,CN1CCN2c3ncccc3Cc3ccccc3[C@@H]2C1,negative,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CN=C24,mirtazapine_R,2D6-Substrate
783,CC(Nc1cc(-c2[nH]c(S(C)=O)nc2-c2ccc(F)cc2)ccn1)c1ccccc1,negative,CC(NC1=NC=CC(=C1)C2=C(N=C([NH]2)[S](C)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4,ML_3603,2D6-Substrate
784,CNCc1cc(=O)oc2cc(OC)ccc12,negative,CNCC1=C[C](=O)OC2=C1C=CC(=C2)OC,MMAMC,2D6-Substrate
785,COc1ccc(C(=O)[C@@H](C)N2CCCC2)cc1,negative,COC1=CC=C(C=C1)C(=O)[C@@H](C)N2CCCC2,MOPPP_R,2D6-Substrate
786,CCCCNC(C)Cc1ccccc1,negative,CCCCNC(C)CC1=CC=CC=C1,N_butyl_amphetamine,2D6-Substrate
787,CNCCCN1c2ccccc2CCc2ccc(Cl)cc21,negative,CNCCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13,N_desmethyl_clomipramine,2D6-Substrate
788,CCNC(C)Cc1ccccc1,negative,CCNC(C)CC1=CC=CC=C1,N_ethyl_amphetamine,2D6-Substrate
789,OC(CNCC(F)(F)F)COc1cccc2ccccc12,negative,OC(CNCC(F)(F)F)COC1=CC=CC2=CC=CC=C12,N_trifluoro_ethyl_desisopropyl_propranolol,2D6-Substrate
790,CCCNCc1cc(=O)oc2cc(OC)ccc12,negative,CCCNCC1=C[C](=O)OC2=C1C=CC(=C2)OC,PMAMC,2D6-Substrate
791,CC(C)NC[C@H](O)COc1cccc2ccccc12,negative,CC(C)NC[C@H](O)COC1=C2C=CC=CC2=CC=C1,propranolol_S,2D6-Substrate
792,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,negative,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C,retinol,2D6-Substrate
793,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1,negative,COC1=CC=C(C=C1)C2=C[C](=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC,tangeretin,2D6-Substrate
794,CC(NCC(O)COc1cccc2ccccc12)C(F)(F)F,negative,CC(NCC(O)COC1=CC=CC2=CC=CC=C12)C(F)(F)F,trifluoro_propranolol,2D6-Substrate
795,CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1,negative,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1,Albendazole,2D6-Substrate
796,Cc1cc(N(C)C)ccc1CC(C)N,negative,CC1=C(C=CC(=C1)N(C)C)CC(C)N,Amiflamine,2D6-Substrate
797,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,negative,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Amoxapine,2D6-Substrate
798,CNS(=O)(=O)Cc1ccc2[nH]cc(CCCN3CCN(c4ncncc4OC)CC3)c2c1,negative,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC,Avitriptan,2D6-Substrate
799,COc1cc(Br)c2oc(C3CCNCC3)cc2c1,negative,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br,Brofaromine,2D6-Substrate
800,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,negative,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O,Dextrorphan,2D6-Substrate
801,CCC(C)(C)NCC(O)COc1ccccc1C(=O)CCc1ccccc1,negative,CCC(C)(C)NCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,Diprafenone,2D6-Substrate
802,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,negative,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC,Etoperidone,2D6-Substrate
803,COc1ccc(C(C)C)cc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1,negative,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3,Ezlopitant,2D6-Substrate
804,CN[C@@]1(c2ccccc2Cl)CCCCC1=O,negative,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2,Ketamine,2D6-Substrate
805,Clc1cccc(N2CCNCC2)c1,negative,C1CN(CCN1)C2=CC(=CC=C2)Cl,m-Chlorophenylpiperazine,2D6-Substrate
806,CNC(=O)Oc1cc(C)c(SC)c(C)c1,negative,CC1=CC(=CC(=C1SC)C)OC(=O)NC,Methiocarb,2D6-Substrate
807,CON=CC1=CCCN(C)C1,negative,CN1CCC=C(C1)C=NOC,Milameline,2D6-Substrate
808,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,negative,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Molindone,2D6-Substrate
809,COc1ccc2c3c1OC1C(O)C=CC4C(C2)NCCC341,negative,COC1=C2C3=C(CC4C5C3(CCN4)C(O2)C(C=C5)O)C=C1,Norcodeine,2D6-Substrate
810,Cc1ccccc1C(OCCN(C)C)c1ccccc1,negative,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Orphenadrine,2D6-Substrate
811,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,negative,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,Papaverine,2D6-Substrate
812,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,negative,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O,Penbutolol,2D6-Substrate
813,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,negative,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,Pentazocine,2D6-Substrate
814,C[C@@H](NC(=Nc1ccncc1)NC#N)C(C)(C)C,negative,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C,Pinacidil,2D6-Substrate
815,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,negative,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,Pregnenolone,2D6-Substrate
816,CCN(CC)C(=O)NC1CC2c3cccc4[nH]cc(c34)CC2N(C)C1,negative,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C,Terguride,2D6-Substrate
817,Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C,negative,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3,Tiagabine,2D6-Substrate
818,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,negative,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3,Valdecoxib,2D6-Substrate
819,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,negative,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,Yohimbine,2D6-Substrate
820,Nc1nc(NC2CC2)c2ncn([C@@H]3C=C[C@H](CO)C3)c2n1,negative,NC1=NC2=C(N=CN2[C@H]3C[C@@H](CO)C=C3)C(N[C@H]4CC4)=N1,Abacavir,-
821,COCc1c(C(=O)OC(C)C)ncc2[nH]c3ccc(OCc4ccccc4)cc3c12,negative,CC(C)OC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4,Abecarnil,-
822,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,negative,OC(=O)COC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl,Aceclofenac,-
823,CC(=O)C[C@H](c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O,negative,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3,Acenocoumarol,-
824,CC(=O)Nc1ccccc1,negative,CC(=O)NC1=CC=CC=C1,Acetanilide,-
825,CC(=O)Nc1nnc(S(N)(=O)=O)s1,negative,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,Acetazolamide,-
826,CC(C)=O,negative,CC(=O)C,Acetone,-
827,CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,negative,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12,Adinazolam,-
828,CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12,negative,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,Alpidem,-
829,Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,negative,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br,Ambroxol,-
830,CCC1(c2ccc(N)cc2)CCC(=O)NC1=O,negative,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,Aminoglutethimide,-
831,Nc1ccccc1,negative,C1=CC=C(C=C1)N,Aniline,-
832,O=C1c2ccccc2C(=O)c2ccccc21,negative,C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O,Anthraquinone,-
833,C[C@H]1[C@@H]2CC[C@H](C)[C@H]3CC[C@]4(C)OO[C@]23[C@@H](O[C@@H]1OC(=O)CCC(=O)O)O4,negative,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O,Artesunate,-
834,O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21,negative,OC1=C([C@H]2CC[C@@H](CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O,Atovaquone,-
835,CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1,negative,CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C,Avasimibe,-
836,OC(c1ccccc1)(c1ccccc1)C1CCNCC1,negative,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O,Azacyclonol,-
837,CCC1(C)CC(OC(=O)CSc2n[nH]c(N)n2)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O,negative,CCC1(CC(C2(C(CCC3(C2C(=O)CC3)C(C1O)C)C)C)OC(=O)CSC4=NNC(=N4)N)C,Azamulin,-
838,CCC[C@@H]1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O,negative,CCC[C@H]1C(=O)N2N(C1=O)C(=NC3=C2C=C(C)C=C3)N(C)C,Azapropazone,-
839,CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1,negative,CN1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=CC=C3,Azatadine,-
840,CN1CCN(CCCCN2C(=O)CN(N=Cc3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,negative,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl,Azimilide,-
841,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,Azithromycin,-
842,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,negative,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1,Benzbromarone,-
843,c1ccccc1,negative,C1=CC=CC=C1,Benzene,-
844,CC(Cc1ccccc1)N(C)Cc1ccccc1,negative,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,Benzfetamine,-
845,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,negative,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Betamethasone,-
846,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,negative,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C,Bexarotene,-
847,CCC(c1ccc(O)c(F)c1)C(C)c1ccc(O)c(F)c1,negative,CCC(C1=CC(=C(C=C1)O)F)C(C)C2=CC(=C(C=C2)O)F,Bifluranol,-
848,CC12C=CC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,negative,CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C,Boldenone,-
849,CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,negative,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Brinzolamide,-
850,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,negative,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Bromocriptine,-
851,Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1,negative,C1=CC=C(C=C1)C2=C(C(=O)NC(=N2)N)Br,Bropirimine,-
852,Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2,negative,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(SC(Br)=C4)N12,Brotizolam,-
853,Nc1nc([O-])c2c(n1)NCC(CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)O)cc1)N2C=O.[Ca+2],negative,C1C(N(C2=C(N1)N=C(N=C2[O-])N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)O.[Ca+2],Calcium folinate,-
854,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,negative,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5,Candesartan,-
855,CC(C)c1nc(COC(N)=O)n(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1,negative,CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl,Capravirine,-
856,CCOC(=O)n1ccn(C)c1=S,negative,CCOC(=O)N1C=CN(C1=S)C,Carbimazole,-
857,CCC[C@@](C)(COC(N)=O)COC(=O)NC(C)C,negative,CCC[C@@](C)(COC(N)=O)COC(=O)NC(C)C,Carisoprodol,-
858,CC(N)C(=O)c1ccccc1,negative,CC(C(=O)C1=CC=CC=C1)N,Cathinone,-
859,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,negative,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Chenodeoxycholic acid,-
860,OC(O)C(Cl)(Cl)Cl,negative,C(C(Cl)(Cl)Cl)(O)O,Chloral hydrate,-
861,O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,negative,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O,Chloramphenicol,-
862,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,negative,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Chlormadinone,-
863,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC=Cc2ccccc2)[C@H]1c1cccc([N+](=O)[O-])c1,negative,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3,Cilnidipine,-
864,CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,negative,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O,Clindamycin,-
865,CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,negative,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5,Clofazimine,-
866,CC(C)(Oc1ccc(Cl)cc1)C(=O)O,negative,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,Clofibric acid,-
867,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,negative,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3,Clopidogrel,-
868,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,negative,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Cortisol,-
869,CN1C(=O)CCC1c1cccnc1,negative,CN1C(CCC1=O)C2=CN=CC=C2,Cotinine,-
870,O=c1ccc2ccccc2o1,negative,C1=CC=C2C(=C1)C=CC(=O)O2,Coumarin,-
871,CCN(CC)CCS(=O)(=O)C1CCN2C(=O)c3coc(n3)CC(=O)CC(O)C=C(C)C=CCNC(=O)C=CC(C)C(C(C)C)OC(=O)C12,negative,CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C,Dalfopristin,-
872,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,negative,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O,Dantrolene,-
873,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,negative,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1,Daunorubicin,-
874,O=C(O)c1ccc(OCCn2ccnc2)cc1,negative,C1=CC(=CC=C1C(=O)O)OCCN2C=CN=C2,Dazoxiben,-
875,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC,negative,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Desogestrel,-
876,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1,negative,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl,Dexloxiglumide,-
877,ClC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl,negative,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl,Dieldrin,-
878,CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1,negative,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F,Difloxacin,-
879,NNc1nnc(NN)c2ccccc12,negative,NNC1=NN=C(NN)C2=C1C=CC=C2,Dihydralazine,-
880,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,negative,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,Dihydroergotamine,-
881,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-],negative,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O.[OH-].[K+].[K+],Dipotassium clorazepate,-
882,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O,Dirithromycin,-
883,CC(C)N(CC[C@](C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,negative,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C,Disopyramide,-
884,Cc1cc(Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O,negative,CC1=CC(=C(C=C1S(=O)(=O)N)S(=O)(=O)N)Cl,Disulfamide,-
885,CCN(CC)C(=S)[S-].[Na+],negative,CCN(CC)C(=S)[S-].[Na+],Ditiocarb sodium,-
886,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,negative,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2,Dofetilide,-
887,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,negative,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14,Doxycycline,-
888,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,negative,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1,Dronabinol,-
889,CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,negative,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,Drospirenone,-
890,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(C(F)(F)F)ccc1C(F)(F)F,negative,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F,Dutasteride,-
891,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,negative,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Ebastine,-
892,NC(N)=Nc1nc(CSCCN=CNS(=O)(=O)c2ccc(Br)cc2)cs1,negative,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,Ebrotidine,-
893,CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1,negative,CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC,Ecabapide,-
894,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,negative,CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5,Efonidipine,-
895,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,negative,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O,Eprosartan,-
896,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,negative,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O,Ergotamine,-
897,CCc1ccccc1,negative,CCC1=CC=CC=C1,Ethylbenzene,-
898,C#C[C@]1(O)CC[C@H]2[C@H]3CCC4=CC(=O)CC[C@H]4[C@H]3C(=C)C[C@]21CC,negative,CC[C@@]12CC(=C)[C@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@@H]1CC[C@@]2(O)C#C,Etonogestrel,-
899,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C1C,negative,CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC,Everolimus,-
900,N#Cc1ccc(C2CCCc3cncn32)cc1,negative,C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N,Fadrozole,-
901,NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,negative,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1,Famotidine,-
902,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,negative,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2,Fenofibrate,-
903,COSc1cn(C)c2cc(F)ccc2c1=O,negative,COSC1=CN(C)C2=C(C=CC(F)=C2)C1=O,Flosequinan,-
904,Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,negative,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F,Flucloxacillin,-
905,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,negative,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O,Flunitrazepam,-
906,O=c1[nH]cc(F)c(=O)[nH]1,negative,FC1=CNC(=O)NC1=O,Fluorouracil,-
907,Fc1cccc2c1OC1CNCC1O2,negative,C1C2C(CN1)OC3=C(O2)C=CC=C3F,Fluparoxan,-
908,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,negative,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2,Flurbiprofen,-
909,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Flurithromycin,-
910,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,negative,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,Flutamide,-
911,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,negative,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,Fluticasone,-
912,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,negative,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3,Fosphenytoin,-
913,CN[C@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,negative,CN[C@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(N)=O,Frovatriptan,-
914,Cc1nc2c([nH]1)c(=O)n(C)c(=O)n2Cc1ccco1,negative,CC1=NC2=C(N1)C(=O)N(C(=O)N2CC3=CC=CO3)C,Furafylline,-
915,COc1ccc(CCN(C)CCC[C@](C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC,negative,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1,Gallopamil,-
916,CC(=O)C1CCC2C3CCC4CC(C)(O)CCC4(C)C3CCC12C,negative,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C,Ganaxolone,-
917,C#CC1(O)C=CC2C3CCC4=CC(=O)CCC4C3CCC21CC,negative,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,Gestodene,-
918,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,negative,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3,Glibenclamide,-
919,Cc1ccc(S(=O)(=O)NC(=O)NN2C[C@H]3CCC[C@H]3C2)cc1,negative,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2,Gliclazide,-
920,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,negative,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O,Glimepiride,-
921,Cc1c(F)c(N2CCN[C@@H](C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,negative,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O,Grepafloxacin,-
922,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,negative,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC,Griseofulvin,-
923,NC(N)=NN=Cc1c(Cl)cccc1Cl,negative,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,Guanabenz,-
924,CN1C(=O)[C@](C)(C2=CCCCC2)C(=O)N=C1O,negative,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O,Hexobarbital,-
925,CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,negative,CN1CCCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Homochlorcyclizine,-
926,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,negative,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Ibutilide,-
927,CC(C)Cn1cnc2c(N)nc3ccccc3c21,negative,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12,Imiquimod,-
928,O=C(O)CCCCC=C(c1ccccc1)c1cccnc1,negative,C1=CC=C(C=C1)C(=CCCCCC(=O)O)C2=CN=CC=C2,Isbogrel,-
929,O=[N+]([O-])OC1COC2C(O[N+](=O)[O-])COC12,negative,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],Isosorbide dinitrate,-
930,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1c1cccc2nonc12,negative,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C,Isradipine,-
931,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,negative,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2,Ivermectin,-
932,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@H]1OC(C)=O,negative,CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(C)=O,Josamycin,-
933,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,negative,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)C=CC(=O)OC(C)(C)C)C(=O)OCC,Lacidipine,-
934,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,negative,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,Leflunomide,-
935,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,negative,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4,Levofloxacin,-
936,NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+],negative,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+],Levothyroxine sodium,-
937,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,negative,C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4,Liarozole,-
938,CN(C)c1ccc(C2CC3(C)C(CCC3(O)C=CCO)C3CCC4=CC(=O)CCC4=C23)cc1,negative,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C,Lilopristone,-
939,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,negative,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Linezolid,-
940,NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,negative,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,Liothyronine,-
941,CC(O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,Lisofylline,-
942,c1ccc2cc(COC3CCNCC3)ccc2c1,negative,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2,Litoxetine,-
943,COC1=CC(=O)OC1C(O)c1ccccc1Cl,negative,COC1=CC(=O)OC1C(C2=CC=CC=C2Cl)O,Losigamone,-
944,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1C2=Cc1ccc(Cl)cc1,negative,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,Lumefantrine,-
945,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC,negative,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC,Malathion,-
946,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1,negative,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3,Mebendazole,-
947,CN(C)CC(Oc1ccccc1)Oc1ccccc1,negative,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2,Medifoxamine,-
948,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,negative,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14,Medroxyprogesterone,-
949,Cc1cccc(Nc2ccccc2C(=O)O)c1C,negative,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,Mefenamic acid,-
950,Cc1ccccc1-n1c(C)nc2ccccc2c1=O,negative,CC1=C(C=CC=C1)N2C(C)=NC3=C(C=CC=C3)C2=O,Methaqualone,-
951,CNC(=O)ON=C(C)SC,negative,CC(=NOC(=O)NC)SC,Methomyl,-
952,COc1c2occc2cc2ccc(=O)oc12,negative,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3,Methoxsalen,-
953,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,negative,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34,Methylergometrine,-
954,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,negative,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,Methylphenidate,-
955,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,negative,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14,Methylprednisolone,-
956,Cc1ncc([N+](=O)[O-])n1CCO,negative,CC1=NC=C(N1CCO)[N+]([O-])=O,Metronidazole,-
957,CCC(C)C(=O)OC1CCC=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,negative,CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O,Mevastatin,-
958,CC1COC2(c3ccccc3Cl)c3cc(Cl)ccc3NC(=O)CN12,negative,CC1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl,Mexazolam,-
959,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H]1OC,negative,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC,Midecamycin,-
960,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,negative,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,Milnacipran,-
961,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1,negative,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1,Montelukast,-
962,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,negative,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1,Moracizine,-
963,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,negative,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,Mosapride,-
964,CCOc1ccc2ccccc2c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)O,negative,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Nafcillin,-
965,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,negative,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,Nalidixic acid,-
966,Cc1cccc(C)c1NC(=O)CN1CCCC1=O,negative,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,Nefiracetam,-
967,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,negative,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O,Niclosamide,-
968,CCCOCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCOCCC)C1c1cccc([N+](=O)[O-])c1,negative,CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOCCC)C)C,Niludipine,-
969,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@@H]1c1cccc([N+](=O)[O-])c1,negative,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C,Nimodipine,-
970,O=[N+]([O-])c1cncn1CCN1CCOCC1,negative,C1COCCN1CCN2C=NC=C2[N+](=O)[O-],Nimorazole,-
971,NN=O,negative,NN=O,Nitrosamine,-
972,CN(C)CCC=C1c2ccccc2COc2ccc(CC(=O)O)cc21,negative,CN(C)CCC=C1C2=C(COC3=C1C=C(CC(O)=O)C=C3)C=CC=C2,Olopatadine,-
973,Cc1c(-c2cnccn2)ssc1=S,negative,CC1=C(SSC1=S)C2=NC=CN=C2,Oltipraz,-
974,O=C(NC1CCSC2CCCC(C(=O)O)N2C1=O)C(S)Cc1ccccc1,negative,C1CC(N2C(C1)SCCC(C2=O)NC(=O)C(CC3=CC=CC=C3)S)C(=O)O,Omapatrilat,-
975,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,negative,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2,Oxcarbazepine,-
976,Clc1ccc(CON=C(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,negative,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1,Oxiconazole,-
977,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc2c1OCO2,negative,CCOC(=O)C1=C(NC(=C(C1C2=C3C(=CC=C2)OCO3)C(=O)OC)C)C,Oxodipine,-
978,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21,negative,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCN(C)CC3)C(F)=C2,Pefloxacin,-
979,c1ccc(C2(N3CCCCC3)CCCCC2)cc1,negative,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,Phencyclidine,-
980,CC[C@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,negative,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3,Phenprocoumon,-
981,CN1C(=O)C[C@H](c2ccccc2)C1=O,negative,CN1C(=O)C[C@@H](C1=O)C2=CC=CC=C2,Phensuximide,-
982,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,negative,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,Phenylbutazone,-
983,CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21,negative,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCNCC3)C(=O)O,Pipemidic acid,-
984,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,negative,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O,Piroxicam,-
985,C#CCC12CCC(=O)C=C1CCC1C3CCC(=O)C3(C)CCC12,negative,CC12CCC3C(C1CCC2=O)CCC4=CC(=O)CCC34CC#C,Plomestane,-
986,CCCN[C@@H]1CCc2nc(N)sc2C1,negative,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2,Pramipexole,-
987,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC=Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,negative,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,Pranidipine,-
988,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,negative,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,Prednisolone,-
989,CCC1(c2ccccc2)C(=O)NCNC1=O,negative,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2,Primidone,-
990,CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1,negative,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC,Proadifen,-
991,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,negative,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,Probenecid,-
992,CCCO,negative,CCCO,Propanol,-
993,CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],negative,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],Pyridostigmine bromide,-
994,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,negative,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,Quercetin,-
995,CCCN1CCCC2Cc3nc(N)ncc3CC21,negative,CCCN1CCCC2C1CC3=CN=C(N=C3C2)N,Quinelorane,-
996,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,negative,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Quinine,-
997,CCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)NC(=O)C2CC(=O)C(CSC3CN4CCC3CC4)CN2C(=O)C(Cc2ccc(N(C)C)cc2)N(C)C(=O)C2CCCN2C1=O,negative,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C,Quinupristin,-
998,COCCCOc1ccnc(CC(=O)c2nc3ccccc3[nH]2)c1C,negative,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1,Rabeprazole,-
999,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,negative,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,Ranolazine,-
1000,O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1,negative,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,Rebamipide,-
1001,CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1,negative,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN,Remacemide,-
1002,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,negative,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O,Repaglinide,-
1003,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,negative,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6,Reserpine,-
1004,CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,negative,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,Resiquimod,-
1005,CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,negative,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O,Rifabutin,-
1006,Nc1nc2ccc(OC(F)(F)F)cc2s1,negative,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,Riluzole,-
1007,CCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](O)CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)OC(=O)CC,negative,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C,Rokitamycin,-
1008,CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1,negative,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O,Roquinimex,-
1009,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]2O[C@@H](C)C[C@H](N(C)C)[C@@H]2O)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,Roxithromycin,-
1010,Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1,negative,CC1=CC(CN2CCC(CC2)=C3/C4=C(CCC5=C3N=CC=C5)C=C(Cl)C=C4)=CN=C1,Rupatadine,-
1011,CC(C)(C)NC[C@@H](O)c1ccc(O)c(CO)c1,negative,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1,Salbutamol,-
1012,C=CCC1([C@H](C)CCC)C(=O)NC(=O)NC1=O,negative,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O,Secobarbital,-
1013,CC1=C(C)C(=O)C([C@H](CCCCCC(=O)O)c2ccccc2)=C(C)C1=O,negative,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O,Seratrodast,-
1014,CC(C)C[C@@H](N(C)C)C1(c2ccc(Cl)cc2)CCC1,negative,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2,Sibutramine,-
1015,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21,negative,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13,Spironolactone,-
1016,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,negative,CCC(=O)N(C1=CC=CC=C1)[C@]2(CCN(CCC3=CC=CS3)CC2)COC,Sufentanil,-
1017,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,negative,COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1,Sulfadimethoxine,-
1018,Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,negative,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1,Sulfadimidine,-
1019,Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,negative,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C,Sulfafurazole,-
1020,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,negative,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,Sulfamethoxazole,-
1021,Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C,negative,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1,Sulfamoxole,-
1022,Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,negative,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2,Sulfapyridine,-
1023,O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,negative,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3,Sulfasalazine,-
1024,O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,negative,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,Sulfinpyrazone,-
1025,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,negative,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O,Sulpiride,-
1026,Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CC2,negative,CC1=NC2=C(CCC(=O)N2CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5)C(C)=N1,Tasosartan,-
1027,CCCCOC(=O)C(=O)Nc1cccc(-c2nn[nH]n2)c1,negative,CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C2=NNN=N2,Tazanolast,-
1028,CC(C)(C)c1cc(CC2SCNC2=O)cc(C(C)(C)C)c1O,negative,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NCS2,Tazofelone,-
1029,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,negative,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F,Tecastemizole,-
1030,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,negative,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C,Telmisartan,-
1031,CN1C(=O)[C@H](O)N=C(c2ccccc2)c2cc(Cl)ccc21,negative,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3,Temazepam,-
1032,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,negative,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7,Teniposide,-
1033,CC(Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,negative,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,Tenofovir,-
1034,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,negative,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O,Tenoxicam,-
1035,CC12CCC3C(CCC4=CC(=O)C=CC43C)C1CCC(=O)O2,negative,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Testolactone,-
1036,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO,negative,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,Tezosentan,-
1037,c1ccc2[nH]c(-c3cscn3)nc2c1,negative,N1C2=C(C=CC=C2)N=C1C3=CSC=N3,Tiabendazole,-
1038,O=C(Cn1c(=O)sc2ccc(Cl)cc21)N1CCN(CCO)CC1,negative,C1CN(CCN1CCO)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O,Tiaramide,-
1039,O=S(Cc1ccccn1)c1nc2ccccc2[nH]1,negative,C1=CC=C2C(=C1)NC(=N2)S(=O)CC3=CC=CC=N3,Timoprazole,-
1040,CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,negative,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,Tipranavir,-
1041,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1,negative,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN5CCN(CC5)C6=CC(=NC(=N6)N7CCCC7)N8CCCC8,Tirilazad,-
1042,Cc1cccc(C)c1NC(=O)[C@H](C)N,negative,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C,Tocainide,-
1043,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1,negative,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1,Topiramate,-
1044,CN(C)CCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1,negative,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,Toremifene,-
1045,CCN(CC)c1cc(C)nc2ncnn12,negative,CCN(CC)C1=CC(=NC2=NC=NN12)C,Trapidil,-
1046,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,negative,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1,Trifluoperazine,-
1047,COc1ccc(CN2CCNCC2)c(OC)c1OC,negative,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,Trimetazidine,-
1048,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,negative,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,Trimetrexate,-
1049,O=[P@@]1(N(CCCl)CCCl)OCCCN1CCCl,negative,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl,Trofosfamide,-
1050,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1.[Cl-],negative,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],Trospium chloride,-
1051,CC=CCC(C)C(=O)C1C(=O)NC(C(C)C)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,negative,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,Valspodar,-
1052,Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1,negative,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,Vanoxerine,-
1053,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC,negative,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,Vesnarinone,-
1054,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,negative,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1,Vindesine,-
1055,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,negative,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3,Voriconazole,-
1056,CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2,negative,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O,Zaltoprofen,-
1057,CN1C2CCC1CC(NC(=O)c1cc(Cl)cc3c1OC(C)(C)C3)C2,negative,CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C,Zatosetron,-
1058,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,negative,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,Zidovudine,-
1059,CC(c1cc2ccccc2s1)N(O)C(N)=O,negative,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,Zileuton,-
1060,CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,negative,CN(C)CCC1=CNC2=C1C=C(C[C@H]3COC(=O)N3)C=C2,Zolmitriptan,-
1061,NS(=O)(=O)Cc1noc2ccccc12,negative,NS(=O)(=O)CC1=NOC2=C1C=CC=C2,Zonisamide,-
1062,Nc1nc2cc(Cl)ccc2o1,negative,C1=CC2=C(C=C1Cl)N=C(O2)N,Zoxazolamine,-
1063,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,negative,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3,Bromperidol,2D6-Substrate
1064,CCc1cccc2cc(C(O)CNC(C)(C)C)oc12,negative,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,Bufuralol,2D6-Substrate
1065,CC(C)(C)NCC(O)COc1ccccc1C#N,negative,CC(C)(C)NCC(COC1=CC=CC=C1C#N)O,Bunitrolol,2D6-Substrate
1066,C(=Cc1ccccc1)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,negative,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4,Cinnarizine,2D6-Substrate
1067,CN1CCN(C2=Nc3cc(F)ccc3Cc3ccccc32)CC1,negative,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F,Fluperlapine,2D6-Substrate
1068,CC(N)Cc1ccc(O)cc1,negative,CC(CC1=CC=C(C=C1)O)N,Hydroxyamfetamine,2D6-Substrate
1069,NCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,negative,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F,Norfluoxetine,2D6-Substrate
1070,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1,negative,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54,Perospirone,2D6-Substrate
1071,CC12CCC(O)CC1=CCC1C2CCC2(C)C(c3cccnc3)=CCC12,negative,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,Abiraterone,-
1072,CNn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21,negative,CNN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Amifloxacin,-
1073,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],negative,CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Aranidipine,-
1074,CC1=CC(=O)C=C2CCC3C4CCC(=O)C4(C)CCC3C12C,negative,CC1=CC(=O)C=C2C1(C3CCC4(C(C3CC2)CCC4=O)C)C,Atamestane,-
1075,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,negative,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Beclometasone,-
1076,O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,negative,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3,Cetirizine,-
1077,CC(C)N=C(N)N=C(N)Nc1ccc(Cl)c(Cl)c1,negative,CC(C)N=C(N)N=C(N)NC1=CC(=C(C=C1)Cl)Cl,Chlorproguanil,-
1078,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,negative,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1,Clonazepam,-
1079,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C(C(=O)CO)CCC12,negative,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O,Corticosterone,-
1080,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1,negative,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,Delapril,-
1081,CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21,negative,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C,Emedastine,-
1082,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,negative,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2,Emivirine,-
1083,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21,negative,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2,Enoxacin,-
1084,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,negative,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34,Ergometrine,-
1085,CCN1C(=O)N[C@@H](c2ccccc2)C1=O,negative,CCN1C(=O)N[C@H](C1=O)C2=CC=CC=C2,Ethotoin,-
1086,COc1c(N2CCN[C@@H](C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,negative,COC1=C(N2CCN[C@@H](C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)[C@H]4CC4,Gatifloxacin,-
1087,Cc1ccc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)nc1,negative,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3,Glipizide,-
1088,CCC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,negative,CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OC)O,Hydroquinidine,-
1089,CN1C(CC(=O)c2ccccc2)CCCC1CC(O)c1ccccc1,negative,CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O,Lobeline,-
1090,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN[C@H](C)C3)c(F)c21,negative,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12,Lomefloxacin,-
1091,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,negative,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O,Lornoxicam,-
1092,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,negative,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4,Losartan,-
1093,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,negative,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O,Meloxicam,-
1094,C#CC1(O)CCC2C3CCc4cc(OC)ccc4C3CCC21C,negative,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,Mestranol,-
1095,CC[C@@]1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,negative,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2,Methylphenobarbital,-
1096,NC(=O)CS(=O)C(c1ccccc1)c1ccccc1,negative,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2,Modafinil,-
1097,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,negative,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O,Nilutamide,-
1098,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1,negative,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1,Nordazepam,-
1099,CN(C)c1ccc(C2CC3(C)C(CCC3(O)CCCO)C3CCC4=CC(=O)CCC4=C23)cc1,negative,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C,Onapristone,-
1100,C[C@H](CN(C)C)CN1c2ccccc2S(=O)(=O)c2ccccc21,negative,C[C@H](CN(C)C)CN1C2=C(C=CC=C2)S(=O)(=O)C3=C1C=CC=C3,Oxomemazine,-
1101,Cn1c(=O)[nH]c2ncn(C)c2c1=O,negative,CN1C=NC2=C1C(=O)N(C(=O)N2)C,Paraxanthine,-
1102,CCC[C@@H](C)C1(CC)C(=O)NC(=O)NC1=O,negative,CCC[C@@H](C)[C@@]1(CC)C(=O)NC(=O)NC1=O,Pentobarbital,-
1103,Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2,negative,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3,Pilsicainide,-
1104,COc1ccc(-c2nc3ccc(C4=NNC(=O)CC4C)cc3[nH]2)cc1,negative,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,Pimobendan,-
1105,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,negative,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,Prednisone,-
1106,CCC1(c2ccncc2)CCC(=O)NC1=O,negative,CCC1(CCC(=O)NC1=O)C2=CC=NC=C2,Rogletimide,-
1107,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,negative,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,Stiripentol,-
1108,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,negative,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,Sulfadoxine,-
1109,Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,negative,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Sulfamerazine,-
1110,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,negative,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1,Sulfamethizole,-
1111,Cc1onc(NS(=O)(=O)c2ccc(N)cc2)c1C,negative,CC1=C(ON=C1NS(=O)(=O)C2=CC=C(C=C2)N)C,Sulfatroxazole,-
1112,C[C@H](C(=O)O)c1ccc(C(=O)c2cccs2)cc1,negative,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2,Suprofen,-
1113,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C,negative,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O,Valsartan,-
1114,O=S(=O)([O-])[O-],negative,[O-]S([O-])(=O)=O,Sodium Sulfate,P450_HP-Inducer
1115,Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,negative,CC1=NC(N)=C(C[N+]2=CSC(CCO)=C2C)C=N1,Thiamine (vit B1),P450_HP-Inducer
1116,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,negative,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO,Desoxycortone,Steroid_11_beta_hydroxylase-Substrate
1117,C[n+]1c2cc(N)ccc2cc2ccc(N)cc21.Cl.Nc1ccc2cc3ccc(N)cc3nc2c1.[Cl-],negative,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4,Acriflavinium Chloride,1B1-Inducer
1118,O=[As]1=[As](=O)O1,negative,O=[As]1=[As](=O)O1,Arsenic Trioxide,1B1-Inhibitor
1119,O=C(O)CCCC[C@@H]1SC[C@H]2NC(=O)N[C@H]21,negative,OC(=O)CCCC[C@@H]1SC[C@H]2NC(=O)N[C@@H]12,Biotin,1B1-Inducer
1120,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1O,negative,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2,Diosmectite,1B1-Inhibitor
1121,CCC1(CC)C(=O)NC(=O)N(C)C1=O,negative,CCC1(CC)C(=O)NC(=O)N(C)C1=O,Metharbital,1B1-Inducer
1122,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr,negative,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr,Mitobronitol,1B1-Inducer
1123,CCN(CC)CCc1nc(-c2ccccc2)no1,negative,CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2,Oxolamine,1B1-Inducer
1124,CNNCc1ccc(C(=O)NC(C)C)cc1,negative,CNNCC1=CC=C(C=C1)C(=O)NC(C)C,Procarbazine,1B1-Substrate
1125,NC(=O)c1ccccc1O,negative,NC(=O)C1=C(O)C=CC=C1,Salicylamide,1B1-Inhibitor
1126,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,negative,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O,Tryptophan,1B1-Inducer
1127,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1,negative,NC1=NC2=C(C(=O)N1)C(CCC3=CC=C(C=C3)C(=O)N[C@H](CCC(O)=O)C(O)=O)=CN2,Pemetrexed,Proton_coupled_folate_transporter-Substrate
1128,CCCC(=O)O,negative,CCCC(O)=O,Hydroxybutyric Acid,Monocarboxylate_transporter_1-Substrate
1129,C[C@@H](O)C(=O)O,negative,C[C@@H](O)C(O)=O,Milchsäure,Monocarboxylate_transporter_1-Substrate
1130,O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1,negative,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1,Niflumic Acid,Monocarboxylate_transporter_1-Inhibitor
1131,Nc1ccc(C(=O)NCC(=O)O)cc1,negative,NC1=CC=C(C=C1)C(=O)NCC(O)=O,Aminohippuric Acid,Solute_carrier_family_22_member_6-Substrate
1132,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,negative,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O,Amoxicillin,Solute_carrier_family_22_member_6-Substrate
1133,N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1,negative,N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3,Cefaclor,Solute_carrier_family_22_member_6-Inhibitor
1134,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,negative,CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN4C=NN=N4)C3=O)C(O)=O)S1,Cefazolin,Solute_carrier_family_22_member_6-Substrate
1135,Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,negative,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,Cidofovir,Solute_carrier_family_22_member_6-Substrate
1136,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21,negative,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5,Fluorescein,Solute_carrier_family_22_member_6-Substrate
1137,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,negative,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1,Lumiracoxib,Solute_carrier_family_22_member_6-Inhibitor
1138,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[C@@H](C(=O)N(C)C)N3)[C@H](C)[C@H]12,negative,C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@H]3CC[C@H](N3)C(=O)N(C)C)=C(N2C1=O)C(O)=O,Meropenem,Solute_carrier_family_22_member_6-Substrate
1139,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)O)C(=O)OC2,negative,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2,Mycophenolic Acid,Solute_carrier_family_22_member_6-Substrate
1140,Nc1nc2c(ncn2COCCO)c(=O)[nH]1,negative,NC1=NC2=C(N=CN2COCCO)C(=O)N1,Aciclovir,Canalicular_multispecific_organic_anion_transporter_1-Substrate
1141,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,negative,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O,Benzylpenicillin,Canalicular_multispecific_organic_anion_transporter_1-Inducer
1142,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,negative,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O,Enoxolone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor
1143,CCc1cccc2c3c([nH]c12)[C@](CC)(CC(=O)O)OCC3,negative,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O,Etodolac,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor
1144,CN[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H]([C@@H](C)NC)CC[C@@H]3N)[C@@H]2O)OC[C@]1(C)O,negative,CN[C@H](C)[C@@H]1CC[C@H](N)[C@H](O1)O[C@@H]2[C@@H](N)C[C@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@@H](NC)[C@@H]3O)[C@H]2O,Gentamicin,Canalicular_multispecific_organic_anion_transporter_1-Inducer
1145,C[C@@H](O)[C@@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O,negative,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@H](CC4=CNC5=CC=CC=C45)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,Octreotide,Canalicular_multispecific_organic_anion_transporter_1-Substrate
1146,O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,negative,OC1=CC=C(C=C1)[C@@]2(OC(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4,Phenolphthalein,Canalicular_multispecific_organic_anion_transporter_1-Substrate
1147,CC(C)(C)NC[C@@H](O)COc1ccc(NC(=O)NC2CCCCC2)cc1,negative,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1,Talinolol,Canalicular_multispecific_organic_anion_transporter_1-Substrate
1148,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,negative,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,Bumetanide,Solute_carrier_family_12_member_2-Inhibitor
1149,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,negative,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,Kanamycin,Solute_carrier_family_12_member_2-Inhibitor
1150,[Li],negative,[Li],Lithium,Solute_carrier_family_12_member_2-Inducer
1151,COc1ccc(OC)c([C@@H](O)[C@@H](C)N)c1,negative,COC1=CC([C@@H](O)[C@@H](C)N)=C(OC)C=C1,Methoxamine,Solute_carrier_family_12_member_2-Inducer
1152,N#C[Fe](C#N)(C#N)(C#N)(C#N)N=O,negative,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N,Nitroprusside,Solute_carrier_family_12_member_2-Inhibitor
1153,O=O,negative,O=O,Oxygen,Solute_carrier_family_12_member_2-Inducer
1154,CC[C@H](C)[C@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O,negative,CC[C@H](C)[C@H]1NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,Oxytocin,Solute_carrier_family_12_member_2-Inducer
1155,[Cl-].[K+],negative,[Cl-].[K+],Potassium Chloride,Solute_carrier_family_12_member_2-Substrate
1156,NCC(=O)CCC(=O)O,negative,NCC(=O)CCC(O)=O,Aminolevulinic Acid,Solute_carrier_family_15_member_2-Substrate
1157,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,negative,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O,Cefadroxil,Solute_carrier_family_15_member_2-Substrate
1158,CCC(=O)O[C@@H](O[P@@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C,negative,CCC(=O)O[C@@H](O[P@@](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(O)=O)[C@H]3CCCCC3)C(C)C,Fosinopril,Solute_carrier_family_15_member_2-Substrate
1159,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,negative,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=C(C[C@H]2C(O)=O)C=CC=C3,Quinapril,Solute_carrier_family_15_member_2-Inhibitor
1160,CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21,negative,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O,Valaciclovir,Solute_carrier_family_15_member_2-Substrate
1161,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCn1cnc2c(=O)nc(N)[nH]c21,negative,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O,Valganciclovir,Solute_carrier_family_15_member_2-Inhibitor
1162,C=CCC1(C(C)C)C(=O)NC(=O)NC1=O,negative,CC(C)[C@]1(CC=C)C(=O)NC(=O)NC1=O,Aprobarbital,2B6-Inducer
1163,CN[C@]1(c2ccccc2Cl)CCCCC1=O,negative,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2,Esketamine,2B6-Substrate
1164,CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1,negative,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2,Ketobemidone,2B6-Substrate
1165,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C,negative,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C,Levoverbenone,2B6-Substrate
1166,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,negative,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2,Permethrin,2B6-Inducer
1167,CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,negative,CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C,Acetylcarnitine,Solute_carrier_family_22_member_5-Substrate
1168,CON=C(C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1,negative,CON=C(/C(=O)N[C@H]1[C@H]2SCC(C[N@+]3(C)CCCC3)=C(N2C1=O)C([O-])=O)C4=CSC(N)=N4,Cefepime,Solute_carrier_family_22_member_5-Inhibitor
1169,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,negative,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](CC5=CNC6=CC=CC4=C56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ergoloid Mesylates,Solute_carrier_organic_anion_transporter_family_member_2B1-Inhibitor
1170,O=C([O-])O,negative,OC([O-])=O,Sodium Bicarbonate,Electroneutral_sodium_bicarbonate_exchanger_1-Substrate
1171,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,negative,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Hydroxyprogesterone,Steroid_21_hydroxylase_21_OHase-Substrate
1172,C=C1C(=CC=C2CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@H](O)C[C@H]1O,negative,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)C[C@@H](O)C3=C,Alfacalcidol,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Substrate
1173,COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC,negative,COC1=CC2=C(C=C1OC)C(CCN3CCN(CC3)C4=CC=CC=C4)=C(C)N2,Oxypertine,Canalicular_multispecific_organic_anion_transporter_2-Inducer
1174,N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,negative,NC(=N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]2CSSCCC(=O)N[C@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O,Desmopressin,Solute_carrier_family_12_member_1-Inducer
1175,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,negative,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1Cl,Hydrochlorothiazide,Solute_carrier_family_12_member_1-Inducer
1176,CC[C@H](C)[C@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O,negative,CC[C@H](C)[C@H]1NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,Vasopressin,Solute_carrier_family_12_member_1-Inducer
1177,NCc1ccc(C(=O)O)cc1,negative,NCC1=CC=C(C=C1)C(O)=O,Aminomethylbenzoic Acid,Solute_carrier_family_15_member_1-Inhibitor
1178,C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)C(=NOCC(=O)O)c3csc(N)n3)[C@H]2SC1,negative,NC1=NC(=CS1)C(=N/OCC(O)=O)C(=O)N[C@H]2[C@H]3SCC(C=C)=C(N3C2=O)C(O)=O,Cefixime,Solute_carrier_family_15_member_1-Substrate
1179,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1,negative,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(O)=O,Cefradine,Solute_carrier_family_15_member_1-Inhibitor
1180,Nc1nc(C(=CCC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@@H]23)cs1,negative,NC1=NC(=CS1)C(=C/CC(O)=O)C(=O)N[C@H]2[C@@H]3SCC=C(N3C2=O)C(O)=O,Ceftibuten,Solute_carrier_family_15_member_1-Substrate
1181,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,negative,OC[C@@H]1CC[C@@H](O1)N2C=NC3=C2N=CNC3=O,Didanosine,Solute_carrier_family_15_member_1-Substrate
1182,N#N,negative,N#N,Nitrogen,Solute_carrier_family_15_member_1-Substrate
1183,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,negative,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,Oseltamivir,Solute_carrier_family_15_member_1-Substrate
1184,O=C(Nc1ccc2c(=O)cc(-c3nnn[nH]3)oc2c1)c1ccc(OCCCCc2ccccc2)cc1,negative,O=C(NC1=CC=C2C(=O)C=C(OC2=C1)C3=NN=NN3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4,Pranlukast,Solute_carrier_family_22_member_11-Inhibitor
1185,C=C1CC[C@@H](O)CC1=CC=C1CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O,negative,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)CCC3=C,Calcifediol,24A-Substrate
1186,CC[C@H](C)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,negative,CC[C@H](C)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC3=CNC4=C3C=CC=C4)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(O)=O,Teriparatide,24A-Inhibitor
1187,N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,negative,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,Amiloride,Solute_carrier_family_22_member_1-Inhibitor
1188,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,negative,NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2,Lamivudine,Solute_carrier_family_22_member_1-Substrate
1189,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,negative,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4,Prazosin,Solute_carrier_family_22_member_1-Inhibitor
1190,Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,negative,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,Ganciclovir,Neutral_amino_acid_transporter_B0-Substrate
1191,NC(=O)CC[C@H](N)C(=O)O,negative,N[C@@H](CCC(N)=O)C(O)=O,Levoglutamide,Neutral_amino_acid_transporter_B0-Substrate
1192,CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O,negative,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2,Cyclobarbital,HLp2-Inducer
1193,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,negative,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4,Vardenafil,HLp2-Substrate
1194,[Br-],negative,[Br-],Bromides,Solute_carrier_family_22_member_2-Substrate
1195,CN1CCN([C@@H](c2ccccc2)c2ccc(Cl)cc2)CC1,negative,CN1CCN(CC1)[C@@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3,Chlorcyclizine,Multidrug_resistance_associated_protein_1-Substrate
1196,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,negative,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4,Dipyridamole,Multidrug_resistance_associated_protein_1-Inhibitor
1197,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,negative,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C(=O)C2=CC=C1,Epirubicin,Multidrug_resistance_associated_protein_1-Inducer
1198,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@@H]4[C@H](CC[C@]3(O)C2)[C@@]2(O)CC[C@H](C3=CC(=O)OC3)[C@@]2(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O,negative,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O,G-strophanthin,Multidrug_resistance_associated_protein_1-Inducer
1199,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,negative,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,Chlorpropamide,2C19-Substrate
1200,COc1ccc2[n-]c(S(=O)Cc3ncc(C)c(OC)c3C)nc2c1,negative,COC1=CC2=C([N-]C(=N2)S(=O)CC3=NC=C(C)C(OC)=C3C)C=C1,Esomeprazole,2C19-Substrate
1201,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,negative,CCC1=CC2=C(S1)N3C(C)=NN=C3CN=C2C4=C(Cl)C=CC=C4,Etizolam,2C19-Substrate
1202,CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,negative,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3,Fosamprenavir,2C19-Inhibitor
1203,O=C(CS(=O)Cc1ccco1)NCC=CCOc1cc(CN2CCCCC2)ccn1,negative,O=C(CS(=O)CC1=CC=CO1)NCC=C/COC2=NC=CC(CN3CCCCC3)=C2,Lafutidine,2C19-Inhibitor
1204,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,negative,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Lynestrenol,2C19-Inducer
1205,CN1C(=O)C[C@@](C)(c2ccccc2)C1=O,negative,CN1C(=O)C[C@](C)(C1=O)C2=CC=CC=C2,Mesuximide,2C19-Inhibitor
1206,COc1ccc2c(c1OC)C(=O)O[C@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,negative,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34,Noscapine,2C19-Inhibitor
1207,COc1cc([C@H]2c3cc4c(cc3C[C@@H]3COC(=O)[C@H]32)OCO4)cc(OC)c1OC,negative,COC1=CC(=CC(OC)=C1OC)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=C2C=C5OCOC5=C4,Podophyllotoxin,2C19-Substrate
1208,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,negative,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3,Quazepam,2C19-Substrate
1209,COc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21,negative,COC1=CC=C2C(=C1)OC3=CC(=CC=C3C24OC(=O)C5=CC=CC=C45)O,3_O_methyl_fluorescein,2C19-Substrate
1210,CCOc1ccc2c(Cl)cc(=O)oc2c1,negative,CCOC1=CC=C2C(=C[C](=O)OC2=C1)Cl,4_chloro_7_ethoxycoumarin,2C19-Substrate
1211,CN1C(=O)CC(=O)N(c2ccc(O)cc2)c2cc(Cl)ccc21,negative,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C3=CC(=CC=C13)Cl,4prime_hydroxy_clobazam,2C19-Substrate
1212,NCCc1c[nH]c2ccc(O)cc12,negative,NCCC1=C[NH]C2=CC=C(O)C=C12,5_hydroxy_tryptamine,2C19-Substrate
1213,CC(C)CCC[C@@H](C)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3C[C@H](O)[C@]12C,negative,CC(C)CCC[C@@H](C)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3C[C@H](O)[C@]12C,5beta_cholestane_3alpha_7alpha_12alpha_triol,2C19-Substrate
1214,O=c1cc(C(F)(F)F)c2ccc(OCc3ccccc3)cc2o1,negative,FC(F)(F)C1=C[C](=O)OC2=CC(=CC=C12)OCC3=CC=CC=C3,7_benzyloxy_4_trifluoromethyl_coumarin,2C19-Substrate
1215,COP(=S)(OC)SCn1nnc2ccccc2c1=O,negative,CO[P](=S)(OC)SC[N]1N=NC2=CC=CC=C2[C]1=O,azinphosmethyl,2C19-Substrate
1216,Cc1ccc(S(=O)(=O)N(C)c2ccnn2-c2ccccc2)cc1,negative,CN(C1=CC=N[N]1C2=CC=CC=C2)[S](=O)(=O)C3=CC=C(C)C=C3,DMZ,2C19-Substrate
1217,O=S1OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl,negative,ClC1=C(Cl)C2(Cl)C3CO[S](=O)OCC3C1(Cl)C2(Cl)Cl,endosulfan,2C19-Substrate
1218,N#Cc1nn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c(N)c1[S@](=O)C(F)(F)F,negative,NC1=C(C(=N[N]1C2=C(Cl)C=C(C=C2Cl)C(F)(F)F)C#N)[S@](=O)C(F)(F)F,fipronil,2C19-Substrate
1219,O=[S@](Cc1cc(OCC2CC2)ccn1)c1nc2ccc(F)cc2[nH]1,negative,FC1=CC=C2N=C([NH]C2=C1)[S@](=O)CC3=NC=CC(=C3)OCC4CC4,H_259_31_R,2C19-Substrate
1220,CN1C(=O)NC(=O)[C@@](C)(C2=CCCCC2)C1=O,negative,CN1C(=O)NC(=O)[C@](C)(C1=O)C2=CCCCC2,hexobarbital_R,2C19-Substrate
1221,C=C(C)[C@@H]1CC=C(C)CC1,negative,CC(=C)[C@H]1CCC(=CC1)C,limonene_S,2C19-Substrate
1222,CC[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,negative,CC[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O,phenprocoumon_S,2C19-Substrate
1223,CCOP(=S)(OCC)SCSCC,negative,CCO[P](=S)(OCC)SCSCC,phorate,2C19-Substrate
1224,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,negative,CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2,sibutramine,2C19-Substrate
1225,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,negative,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C3=C1C=CC(=C3)Cl,temazepam,2C19-Substrate
1226,CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,negative,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,terbinafine,2C19-Substrate
1227,CCNc1nc(NC(C)(C)C)nc(SC)n1,negative,CCNC1=NC(=NC(=N1)SC)NC(C)(C)C,terbutryn,2C19-Substrate
1228,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,negative,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,thalidomide,2C19-Substrate
1229,O=C(c1cccs1)c1ccc(OCCCO)c(Cl)c1Cl,negative,OCCCOC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CC=CS2,tienilic_acid_deriv_3,2C19-Substrate
1230,COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,negative,COC1=CC=C2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2=C1,3_methylether_estradiol,2C19-Substrate
1231,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C=O)C(C)(C)CCC1,negative,CC(=C\C=O)/C=C/C=C(C)\C=C\C1=C(C)CCCC1(C)C,9_cis_retinal,2C19-Substrate
1232,CCNc1nc(NC(C)C)nc(SC)n1,negative,CCNC1=NC(=NC(=N1)SC)NC(C)C,ametryne,2C19-Substrate
1233,CC(C)CC(O)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1,negative,CC(C)CC(O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2,bortezomib_M1_M2,2C19-Substrate
1234,OCCc1ccccc1Nc1c(Cl)cccc1Cl,negative,OCCC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl,diclofenac_deriv_2,2C19-Substrate
1235,Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1,negative,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3[NH]2,lansoprazole_R,2C19-Substrate
1236,COc1ccc(C(c2ccc(OC)cc2)C(Cl)(Cl)Cl)cc1,negative,COC1=CC=C(C=C1)C(C2=CC=C(OC)C=C2)C(Cl)(Cl)Cl,methoxychlor,2C19-Substrate
1237,O=C1CC(=O)N(c2ccccc2)c2cc(Cl)ccc2N1,negative,ClC1=CC=C2NC(=O)CC(=O)N(C3=CC=CC=C3)C2=C1,N_desmethyl_clobazapam,2C19-Substrate
1238,COc1ccc2[nH]c([S@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,negative,COC1=CC=C2[NH]C(=NC2=C1)[S@](=O)CC3=NC=C(C)C(=C3C)OC,omeprazole_R,2C19-Substrate
1239,COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,negative,COC1=CC=C2[NH]C(=NC2=C1)[S@@](=O)CC3=NC=C(C)C(=C3C)OC,omeprazole_S,2C19-Substrate
1240,C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21C,negative,C[C@]12CC(=C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C,org_30659_tosagestin,2C19-Substrate
1241,CCNc1nc(Cl)nc(NC(C)(C)C)n1,negative,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C,terbutylazine,2C19-Substrate
1242,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,testosterone,2C19-Substrate
1243,CC(=O)C[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,negative,CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O,warfarin_S,2C19-Substrate
1244,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,negative,CC[C@@]1(CCC(C)C)C(=O)NC(=O)NC1=O,Amobarbital,Coumarin_7_hydroxylase-Inducer
1245,O=C1C(=C2Nc3ccc(S(=O)(=O)[O-])cc3C2=O)Nc2ccc(S(=O)(=O)[O-])cc21,negative,[O-]S(=O)(=O)C1=CC=C2NC(C(=O)C2=C1)=C3NC4=CC=C(C=C4C3=O)S([O-])(=O)=O,Indigo Carmine,Coumarin_7_hydroxylase-Inhibitor
1246,OCc1cccnc1,negative,OCC1=CC=CN=C1,Nicotinyl Alcohol (pyridylcarbinol),Coumarin_7_hydroxylase-Substrate
1247,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,negative,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,Arbekacin,N_acetyltransferase-Substrate
1248,COc1c2ccoc2cc2oc(=O)ccc12,negative,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3,Bergapten,N_acetyltransferase-Inhibitor
1249,C[N+](C)(C)CCOC(N)=O,negative,C[N+](C)(C)CCOC(N)=O,Carbachol,N_acetyltransferase-Inhibitor
1250,CC(C)NNC(=O)c1ccncc1,negative,CC(C)NNC(=O)C1=CC=NC=C1,Iproniazide,N_acetyltransferase-Inhibitor
1251,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,negative,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,Lindane,N_acetyltransferase-Inducer
1252,CCN[C@@H]1C[C@H](N)[C@@H](O[C@@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,negative,CCN[C@@H]1C[C@H](N)[C@@H](O[C@@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O,Netilmicin,N_acetyltransferase-Substrate
1253,CNC[C@@H](O)c1ccc(O)cc1,negative,CNC[C@@H](O)C1=CC=C(O)C=C1,Oxedrine,N_acetyltransferase-Inhibitor
1254,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,negative,NS(=O)(=O)C1=CC=C(C=C1)N2CCCCS2(=O)=O,Sultiame,N_acetyltransferase-Inducer
1255,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,negative,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,Tobramycin,N_acetyltransferase-Substrate
1256,CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C,negative,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,Adefovir Dipivoxil,2C9-Inhibitor
1257,CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,negative,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O,Capecitabine,2C9-Inhibitor
1258,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,negative,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,Clevidipine,2C9-Inhibitor
1259,C[C@H](CN(C)C)CN1c2ccccc2Sc2ccc(C#N)cc21,negative,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2,Cyamemazine,2C9-Substrate
1260,CN1CCN(C(c2ccccc2)c2ccccc2)CC1,negative,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,Cyclizine,2C9-Inhibitor
1261,NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,negative,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,Diclofenamide,2C9-Inducer
1262,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2OC(=CCCCC(=O)O)C[C@@H]21,negative,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2OC(C[C@H]12)=C/CCCC(O)=O,Epoprostenol,2C9-Substrate
1263,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,negative,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O,Nimesulide,2C9-Inhibitor
1264,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,negative,OC(=O)CCC1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3,Oxaprozin,2C9-Substrate
1265,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(C=NNO)cc1)C1CCCCC1,negative,CCOC(=O)CN[C@H]([C@H]1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C=NNO,Ximelagatran,2C9-Substrate
1266,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O,17_beta_estradiol,2C9-Substrate
1267,CC(C)(C)C1CCC(C2=C(O)c3ccccc3C(=O)C2=O)CC1,negative,CC(C)(C)C1CCC(CC1)C2=C(O)C3=CC=CC=C3C(=O)C2=O,58C80_tautomer_1,2C9-Substrate
1268,NC(=O)c1c(Cl)c(-c2cccnc2)n2c1CCCC2,negative,NC(=O)C1=C2CCCC[N]2C(=C1Cl)C3=CC=CN=C3,CMV_423,2C9-Substrate
1269,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)OC)cc(OC)c3c1OCO3)OCO2,negative,COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3C(=O)OC)OC,DDB_aka_BDD,2C9-Substrate
1270,CCc1cccc2c3c([nH]c12)[C@@](CC)(CC(=O)O)OCC3,negative,CCC1=C2[NH]C3=C(CCO[C@]3(CC)CC(O)=O)C2=CC=C1,etodolac_R,2C9-Substrate
1271,Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,negative,NC1=CC=C(C(=C1)C(F)(F)F)[N](=O)=O,FLU,2C9-Substrate
1272,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,negative,C[C@@H](C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2,flurbiprofen_R,2C9-Substrate
1273,O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,negative,OC1=CC(=C2[C](=O)C(=C(OC2=C1)C3=CC=CC=C3)O)O,galangin,2C9-Substrate
1274,CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1,negative,CC(C)CC1=CC=C(C=C1)[C@@H](C)C(O)=O,ibuprofen_R,2C9-Substrate
1275,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,negative,CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)Cl,losartan,2C9-Substrate
1276,C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(O)c2C(=O)O1,negative,C[C@@H]1CC2=C(C(=C(C=C2Cl)C(=O)N[C@@H](CC3=CC=CC=C3)C(O)=O)O)C(=O)O1,ochratoxin_A,2C9-Substrate
1277,CN(CCOc1ccc(C[C@H]2SC(=O)NC2=O)cc1)c1ccccn1,negative,CN(CCOC1=CC=C(C[C@H]2SC(=O)NC2=O)C=C1)C3=CC=CC=N3,rosiglitazone_R,2C9-Substrate
1278,O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)C2CC[C@@H]1C2,negative,OC(=O)CCC\C=C/C[C@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3,S_145,2C9-Substrate
1279,Cc1ccsc1-c1ccc([C@H](C)C(=O)O)cc1,negative,C[C@H](C(O)=O)C1=CC=C(C=C1)C2=C(C)C=CS2,S_MTPPA,2C9-Substrate
1280,O=C1C(CCSc2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,negative,O=C1C(CCSC2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4,sulfinpyrazone_sulfide,2C9-Substrate
1281,C[C@@H](C(=O)O)c1ccc(C(=O)c2cccs2)cc1,negative,C[C@@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2,suprofen_R,2C9-Substrate
1282,CN1/C(=C(/O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O,negative,CN1\C(=C(\O)NC2=CC=CC=N2)C(=O)C3=C(C=CS3)[S]1(=O)=O,tenoxicam,2C9-Substrate
1283,O=C(O)CC[C@H]1[C@@H](NS(=O)(=O)c2ccccc2)C2CC[C@@H]1C2,negative,OC(=O)CC[C@@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3,tetranor,2C9-Substrate
1284,O=C(O)COc1ccc(C(=O)c2ccsc2)c(Cl)c1Cl,negative,OC(=O)COC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CSC=C2,tienilic_acid_deriv_3_isomer,2C9-Substrate
1285,COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(=O)O)cc1,negative,COC1=C(C(=CC=C1)OC)C2=CC=C(C[C@H](NC(=O)C3=C(Cl)C=CC=C3Cl)C(O)=O)C=C2,TR_14035,2C9-Substrate
1286,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,negative,COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F,vicriviroc,2C9-Substrate
1287,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1CC(F)(F)F,negative,FC1=CC=CC=C1C2=NCC(=O)N(CC(F)(F)F)C3=CC=C(Cl)C=C23,2_oxo_quazepam,2C9-Substrate
1288,O=C(O)Cc1cc(O)ccc1Nc1c(Cl)cccc1Cl,negative,OC(=O)CC1=CC(=CC=C1NC2=C(Cl)C=CC=C2Cl)O,5_hydroxy_diclofenac,2C9-Substrate
1289,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1,negative,CC1=C(\C=C\C(C)=C/C=C/C(C)=C/C(O)=O)C(C)(C)CCC1,9_cis_retinoic_acid,2C9-Substrate
1290,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,negative,CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1,all_trans_retinoic_acid,2C9-Substrate
1291,COc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)N(C)CC3,negative,COC1=CC2=C(C[C@@H]3[C@@H]4CCCC[C@]24CCN3C)C=C1,dextromethorphan,2C9-Substrate
1292,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,negative,COC1=CC=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O,kaempferide,2C9-Substrate
1293,CCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,negative,CCCCC1=NC(=C(C=O)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)Cl,losartan_carboxaldehyde_EXP_3179,2C9-Substrate
1294,O=C(O)COc1ccc(C(=O)c2cccs2)cc1,negative,OC(=O)COC1=CC=C(C=C1)C(=O)C2=CC=CS2,suprofen_desmethyl,2C9-Substrate
1295,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1O,negative,COC1=C(O)C=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O,tamarixetin,2C9-Substrate
1296,O=C(c1cccs1)c1ccc(O)c(Cl)c1Cl,negative,OC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CC=CS2,tienilic_acid_deriv_1,2C9-Substrate
1297,O=C(c1cccs1)c1ccc(OCc2nnn[nH]2)c(Cl)c1Cl,negative,ClC1=C(Cl)C(=CC=C1OCC2=NN=N[NH]2)C(=O)C3=CC=CS3,tienilic_acid_newderiv_9,2C9-Substrate
1298,CC(O)(CC(=O)O)CC(=O)O,negative,CC(O)(CC(O)=O)CC(O)=O,Meglutol,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor
1299,Clc1ccc([C@@H](Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1,negative,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl,Sertaconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor
1300,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,negative,CC(C)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2,Terconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor
1301,NC(=O)N1C(=O)C(=C(O)c2cccs2)c2cc(Cl)ccc21,negative,NC(=O)N1C(=O)C(=C(/O)C2=CC=CS2)C3=C1C=CC(Cl)=C3,Tenidap,Electrogenic_sodium_bicarbonate_cotransporter_1-Inhibitor
1302,Nc1ccc(C(=O)O)c(O)c1,negative,NC1=CC(O)=C(C=C1)C(O)=O,Aminosalicylic Acid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate
1303,O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12,negative,[O-]C(=O)C1=C(CS[C@@H]2[C@H](NC(=O)CC3=CC=CS3)C(=O)N12)C[N+]4=CC=CC=C4,Cefaloridine,2C8-Substrate
1304,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,negative,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,Mometasone,2C8-Inhibitor
1305,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,negative,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C,Naloxone,2C8-Substrate
1306,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,negative,CCOC(=O)C1=CC=C(N=C1)C#CC2=CC3=C(SCCC3(C)C)C=C2,Tazarotene,2C8-Substrate
1307,COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC,negative,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(=C(N)C=C3OC)Cl,cisapride,2C8-Substrate
1308,CCCCN(CCCC)CC[C@@H](O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,negative,CCCCN(CCCC)CC[C@@H](O)C1=CC2=C(Cl)C=C(Cl)C=C2C3=C1C=CC(=C3)C(F)(F)F,halofantrine_R,2C8-Substrate
1309,Fc1cccc(CCN2CCN(CCCc3c[nH]c4ccc(-n5cnnc5)cc34)CC2)c1,negative,FC1=CC=CC(=C1)CCN2CCN(CCCC3=C[NH]C4=CC=C(C=C34)[N]5C=NN=C5)CC2,L_775_606,2C8-Substrate
1310,CCOP(=O)(Cc1ccc(C(=O)Nc2ccc(Br)cc2C#N)cc1)OCC,negative,CCO[P](=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(Br)C=C2)C#N)OCC,NO_1886,2C8-Substrate
1311,COc1ccc(CCNCCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,negative,COC1=C(OC)C=C(CCNCCC[C@@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1,norverapamil_R,2C8-Substrate
1312,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,negative,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12,simvastatin_hydroxy_acid,2C8-Substrate
1313,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,negative,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(=C1C5(C)C)C,taxol,2C8-Substrate
1314,Cc1c(C)c2c(c(C)c1O)CC[C@](C)(COc1ccc(C[C@H]3SC(=O)NC3=O)cc1)O2,negative,CC1=C(O)C(=C2CC[C@](C)(COC3=CC=C(C[C@H]4SC(=O)NC4=O)C=C3)OC2=C1C)C,troglitazone,2C8-Substrate
1315,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,negative,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4CC5=C6C(=C(O)C=C5)O[C@@H]2[C@@]36CCN4CC7CC7,buprenorphine,2C8-Substrate
1316,CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)n2C1,negative,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(=O)O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O,licofelone_M1,2C8-Substrate
1317,COc1ccc(CCNCCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,negative,COC1=C(OC)C=C(CCNCCC[C@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1,norverapamil_S,2C8-Substrate
1318,COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,negative,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1,verapamil_R,2C8-Substrate
1319,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,negative,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2,Latanoprost,Solute_carrier_organic_anion_transporter_family_member_2A1-Inhibitor
1320,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,negative,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(CC(O)=O)C2=O,Benazepril,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor
1321,CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1,negative,CN(C)CCN1N=NN=C1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CC4=CSC(N)=N4)C3=O)C(O)=O,Cefotiam,Solute_carrier_family_22_member_8-Substrate
1322,NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O,negative,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O,Chlorothiazide,Solute_carrier_family_22_member_8-Substrate
1323,O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,negative,OC1=CC=C(C=C1)[C@@]2(OS(=O)(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4,Phenolsulfonphthalein,Solute_carrier_family_22_member_8-Substrate
1324,C[C@@H](Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1,negative,C[C@@H](CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C2=CC=CC=C2,Benfluorex,UGT-Inducer
1325,C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]21CCC(=O)O1,negative,C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5,Canrenone,UGT-Inhibitor
1326,Cc1ncc2c(c1O)CO[C@@H]2c1ccc(Cl)cc1,negative,CC1=NC=C2[C@H](OCC2=C1O)C3=CC=C(Cl)C=C3,Cicletanine,UGT-Substrate
1327,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,negative,CN1CCC(CC1)=C2/C3=C(C=CC=C3)C=CC4=C2C=CC=C4,Cyproheptadin,UGT-Substrate
1328,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,negative,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Dasatinib,UGT-Inhibitor
1329,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,negative,OC(=O)C1=C(O)C=CC(=C1)C2=C(F)C=C(F)C=C2,Diflunisal,UGT-Substrate
1330,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,negative,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Erlotinib,UGT-Inhibitor
1331,NC(=O)N1c2ccccc2C[C@H](O)c2ccccc21,negative,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2,Eslicarbazepine,UGT-Substrate
1332,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,negative,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,Febuxostat,UGT-Substrate
1333,Cc1cc(=O)oc2cc(O)ccc12,negative,CC1=CC(=O)OC2=C1C=CC(O)=C2,Hymecromone,UGT-Inhibitor
1334,O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1,negative,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O,Mitiglinide,UGT-Substrate
1335,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,negative,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,Nilotinib,UGT-Inhibitor
1336,CO[C@@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@@]3(CO3)C[C@H](C)[C@H](O[C@H]3O[C@@H](C)C[C@@H](N(C)C)[C@H]3O)[C@H]2C)O[C@@H](C)[C@H]1O,negative,CO[C@@H]1C[C@@H](O[C@@H](C)[C@H]1O)O[C@H]2[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C,Oleandomycin,UGT-Substrate
1337,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,negative,CC1=CC(=C(O)C(C)=C1CC2=NCCN2)C(C)(C)C,Oxymetazoline,UGT-Substrate
1338,C[C@H](C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1,negative,C[C@H](C(O)=O)C1=CC(Cl)=C(C=C1)N2CC=CC2,Pirprofen,UGT-Substrate
1339,O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,negative,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,Pitavastatin,UGT-Inhibitor
1340,CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,negative,[H][C@@](C)(O)[C@]([H])(CC)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@]2([H])CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,Posaconazole,UGT-Substrate
1341,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,negative,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,Raltegravir,UGT-Substrate
1342,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,negative,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Sorafenib,UGT-Inhibitor
1343,OCCSCCCCCCCCCCSCCO,negative,OCCSCCCCCCCCCCSCCO,Tiadenol,UGT-Inducer
1344,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,negative,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,Alprostadil,Multidrug_resistance_associated_protein_4-Substrate
1345,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,negative,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F,Gemcitabine,Multidrug_resistance_associated_protein_5-Inducer
1346,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,negative,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,Cladribine,ATP_binding_cassette_sub_family_G_member_2-Substrate
1347,O=C(OC[C@H](O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,negative,OC[C@@H](O)COC(=O)C1=C(NC2=C3C=CC(Cl)=CC3=NC=C2)C=CC=C1,Glafenine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor
1348,O=C1CN(N=Cc2ccc([N+](=O)[O-])o2)C(=O)N1,negative,[O-][N+](=O)C1=CC=C(O1)C=NN2CC(=O)NC2=O,Nitrofurantoin,ATP_binding_cassette_sub_family_G_member_2-Substrate
1349,Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C,negative,CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2,Riboflavin (vit B2),ATP_binding_cassette_sub_family_G_member_2-Substrate
1350,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,negative,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O,Topotecan,ATP_binding_cassette_sub_family_G_member_2-Substrate
1351,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ncc[nH]1)[C@H](C)O)[C@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C,negative,CC(C)C[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC2=NC=CN2)[C@H](C)O)[C@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O,Secretin,Ileal_sodiumbile_acid_cotransporter-Inducer
1352,C=C1CC[C@H](O)CC1=CC=C1CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)C=C[C@H](C)C(C)C,negative,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C,Ergocalciferol,Arachidonic_acid_epoxygenase-Substrate
1353,C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1,negative,C[C@H](CC1=CC=C(O)C(O)=C1)[C@@H](C)CC2=CC(O)=C(O)C=C2,Masoprocol,Arachidonic_acid_epoxygenase-Inhibitor
1354,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,negative,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,Fingolimod,4F2-Substrate
1355,CC(C=CC1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(=O)O,negative,CC1=C(C=CC(C)=C/C=C/C(C)=C/C(O)=O)C(C)(C)CCC1,Alitretinoin,1A2-Inhibitor
1356,O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1,negative,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,Anagrelide,1A2-Substrate
1357,CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@@H](CO)c1ccccc1)C2,negative,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@@H](CO)C3=CC=CC=C3,Atropine,1A2-Inhibitor
1358,C[C@H](C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,negative,C[C@H](C(O)=O)C1=CC2=C(OC(=N2)C3=CC=C(Cl)C=C3)C=C1,Benoxaprofen,1A2-Inducer
1359,CC(C)(C)NC[C@H](O)c1cc(Cl)c(N)c(Cl)c1,negative,CC(C)(C)NC[C@H](O)C1=CC(Cl)=C(N)C(Cl)=C1,Clenbuterol,1A2-Substrate
1360,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,negative,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,Clobetasol,1A2-Inhibitor
1361,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1,negative,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2,Cypermethrin,1A2-Substrate
1362,CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1,negative,CC1(C)[C@@H](C=C(/Br)Br)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2,Decamethrin,1A2-Substrate
1363,COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1,negative,COC(=O)NC1=NC2=C(N1)C=CC(SC3=CC=CC=C3)=C2,Fenbendazole,1A2-Inducer
1364,Cc1ccc(C(C)C)cc2c(C)ccc1-2,negative,CC(C)C1=CC2=C(C)C=CC2=C(C)C=C1,Guajazulen,1A2-Substrate
1365,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,negative,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,Idebenone,1A2-Substrate
1366,C[N+](C)([O-])CCCN1c2ccccc2CCc2ccccc21,negative,C[N+](C)([O-])CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,Imipramine Oxide,1A2-Substrate
1367,Cc1cccc(CN2CCN([C@@H](c3ccccc3)c3ccc(Cl)cc3)CC2)c1,negative,CC1=CC(CN2CCN(CC2)[C@@H](C3=CC=CC=C3)C4=CC=C(Cl)C=C4)=CC=C1,Meclozin,1A2-Inhibitor
1368,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,negative,CO[C@@]12[C@H](COC(N)=O)C3=C(N1C[C@@H]4N[C@H]24)C(=O)C(C)=C(N)C3=O,Mitomycin,1A2-Inducer
1369,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,negative,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1,Nitrazepam,1A2-Inducer
1370,C[C@@H](N)[C@@H](O)c1ccccc1,negative,C[C@@H](N)[C@@H](O)C1=CC=CC=C1,Phenylpropanolamine,1A2-Inhibitor
1371,Cc1ccc(=O)n(-c2ccccc2)c1,negative,CC1=CN(C(=O)C=C1)C1=CC=CC=C1,Pirfenidone,1A2-Substrate
1372,NC(=O)c1cnccn1,negative,NC(=O)C1=CN=CC=N1,Pyrazinamide,1A2-Substrate
1373,C#CCNC1CCc2ccccc21,negative,C#CCNC1CCC2=CC=CC=C12,Rasagiline,1A2-Substrate
1374,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,negative,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO,Sorbitol,1A2-Inhibitor
1375,C[C@@H]1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1,negative,C[C@@H]1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=C(F)C=C(F)C=C4)C(O)=O,Temafloxacin,1A2-Substrate
1376,Clc1ccc2nsnc2c1NC1=NCCN1,negative,ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1,Tizanidine,1A2-Substrate
1377,CS(=O)(=O)OC[C@H](O)[C@H](O)COS(C)(=O)=O,negative,CS(=O)(=O)OC[C@H](O)[C@H](O)COS(C)(=O)=O,Treosulfan,1A2-Inhibitor
1378,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,negative,NC1=NC2=C(N=C(C3=CC=CC=C3)C(N)=N2)C(N)=N1,Triamterene,1A2-Inhibitor
1379,CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2,negative,CC(=O)NC1=CC=C2C(=C1)CC3=CC=CC=C23,2_acetylamino_fluorene,1A2-Substrate
1380,Cn1c(N)nc2ncc(-c3ccccc3)cc21,negative,C[N]1C(=NC2=NC=C(C=C12)C3=CC=CC=C3)N,2_amino_1_methyl_6_phenylimidazo_4_5_b_pyridine,1A2-Substrate
1381,Cc1cnc2ccc3c(nc(N)n3C)c2n1,negative,C[N]1C(=NC2=C1C=CC3=NC=C(C)N=C23)N,2_amino_3_8_dimethylimidazo_4_5_f_quinoxaline,1A2-Substrate
1382,Cn1c(N)nc2c3cccnc3ccc21,negative,C[N]1C(=NC2=C1C=CC3=NC=CC=C23)N,2_amino_3_methylimidazo_4_5_f_quinoline,1A2-Substrate
1383,Nc1ccc(-c2ccccc2)cc1,negative,NC1=CC=C(C=C1)C2=CC=CC=C2,4_aminobiphenyl,1A2-Substrate
1384,c1ccc(COc2ccc3cccnc3c2)cc1,negative,C(OC1=CC=C2C=CC=NC2=C1)C3=CC=CC=C3,7_benzyloxy_quinoline,1A2-Substrate
1385,CCOc1ccc2nc3ccc(=O)cc-3oc2c1,negative,CCOC1=CC=C2N=C3C=C[C](=O)C=C3OC2=C1,7_ethoxy_resorufin,1A2-Substrate
1386,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2,negative,COC1=CC2=C([C@@H]3C=CO[C@@H]3O2)C4=C1C5=C(C(=O)CC5)[C](=O)O4,aflatoxin_B1,1A2-Substrate
1387,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,negative,OC1=CC=C(C=C1)C2=C[C](=O)C3=C(O2)C=C(O)C=C3O,apigenin,1A2-Substrate
1388,Cc1nc2c([nH]1)c(=O)n(C)c(=O)n2CC1CCCCC1,negative,C[N]1[C](=O)[N](CC2CCCCC2)C3=C([NH]C(=N3)C)[C]1=O,BRN_4201400,1A2-Substrate
1389,Nc1nc(=O)c(Br)c(-c2ccccc2)[nH]1,negative,NC1=N[C](=O)C(=C([NH]1)C2=CC=CC=C2)Br,bropirimine,1A2-Substrate
1390,c1ccc2c(c1)ccc1nc3ccc4ccccc4c3cc12,negative,C1=CC=C2C(=C1)C=CC3=NC4=CC=C5C=CC=CC5=C4C=C23,dibenzacridine,1A2-Substrate
1391,Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C,negative,CC1=CC=C2[C](=O)C3=C(OC2=C1C)C(=CC=C3)CC(O)=O,DMXAA,1A2-Substrate
1392,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O,negative,COC1=CC=C(C=C1O)[C@@H]2CC(=O)C3=C(O)C=C(O)C=C3O2,hesperetin,1A2-Substrate
1393,CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1,negative,CN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=N[N]23)C(=O)C4=CC=CS4,indiplon,1A2-Substrate
1394,CC(CO)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,negative,CC(CO)OC1=CC=C2[C](=O)C(=COC2=C1)C3=CC=CC=C3,ipriflavone_M4,1A2-Substrate
1395,C=CCc1cc(OC)c2c(c1)OCO2,negative,COC1=C2OCOC2=CC(=C1)CC=C,myristicin,1A2-Substrate
1396,COc1ccc(NC(C)=O)cc1,negative,COC1=CC=C(NC(C)=O)C=C1,O_methyl_acetaminophen,1A2-Substrate
1397,Nc1nc(OCc2ccccc2)c2nc[nH]c2n1,negative,NC1=NC2=C(N=C[NH]2)C(=N1)OCC3=CC=CC=C3,O6_benzylguanine,1A2-Substrate
1398,c1ccc2c(c1)ccc1ccccc12,negative,C1=CC=C2C(=C1)C=CC3=CC=CC=C23,phenanthrene,1A2-Substrate
1399,COc1ccc2[nH]c3c([N+](=O)[O-])ccc4c3c(nn4CCCN(C)C)c2c1,negative,COC1=CC2=C(NC3=C(C=CC4=C3C2=N[N]4CCCN(C)C)[N](=O)=O)C=C1,pyrazolo_acridine,1A2-Substrate
1400,OC(CCC[n+]1ccc(-c2ccc(Cl)cc2)cc1)c1ccc(F)cc1,negative,OC(CCC[N+]1=CC=C(C=C1)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3,RHP+,1A2-Substrate
1401,Cc1c2ccccc2nc2c1ccc1ccccc12,negative,CC1=C2C=CC3=C(C=CC=C3)C2=NC4=CC=CC=C14,7_methyl_benzacridine,1A2-Substrate
1402,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,negative,OC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3[C]2=O)O)O,genistein,1A2-Substrate
1403,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,negative,OC1=CC=C(C=C1)C2=C(O)[C](=O)C3=C(O)C=C(O)C=C3O2,kaempferol,1A2-Substrate
1404,O=C1C[C@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,negative,OC1=CC=C(C=C1)[C@H]2CC(=O)C3=C(O)C=C(O)C=C3O2,naringenin,1A2-Substrate
1405,CC(=O)Nc1ccc(OC(C)C)cc1,negative,CC(C)OC1=CC=C(NC(C)=O)C=C1,O_isopropyl_acetaminophen,1A2-Substrate
1406,C[C@H](N)[C@H](O)c1cccc(O)c1,negative,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1,Metaraminol,Sodium_dependent_noradrenaline_transporter-Substrate
1407,CC(=O)N[C@H](CS)C(=O)O,negative,CC(=O)N[C@H](CS)C(O)=O,Acetylcysteine,Multidrug_resistance_protein_1-Inducer
1408,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,negative,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O,Cytarabine,Multidrug_resistance_protein_1-Inducer
1409,Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,negative,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4Cl,Dicloxacillin,Multidrug_resistance_protein_1-Substrate
1410,O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1,negative,OC(=O)CCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2,Fenbufen,Multidrug_resistance_protein_1-Inducer
1411,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,negative,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C=CC6=CC(OC)=C(OC)C(OC)=C6,Rescinnamine,Multidrug_resistance_protein_1-Inducer
1412,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,negative,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,Deferoxamine,1A1-Inhibitor
1413,CN[C@@]1(C)[C@H]2CC[C@H](C2)C1(C)C,negative,CN[C@@]1(C)[C@H]2CC[C@H](C2)C1(C)C,Mecamylamine,1A1-Inducer
1414,COC1=C[C@@H](C)[C@@H]2C[C@@H]3OC(=O)C[C@H]4C(C)=C(OC)C(=O)[C@H]([C@@]2(C)C1=O)[C@]34C,negative,COC1=C[C@@H](C)[C@@H]2C[C@@H]3OC(=O)C[C@H]4C(C)=C(OC)C(=O)[C@@H]([C@]34C)[C@@]2(C)C1=O,Quassia,1A1-Inhibitor
1415,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,negative,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,Retigabine,1A1-Substrate
1416,N[C@@H]1CONC1=O,negative,N[C@@H]1CONC1=O,Cycloserine,Proton_coupled_amino_acid_transporter_1-Substrate
1417,N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O,negative,N[C@@H](CC1=CNC2=C1C=C(O)C=C2)C(O)=O,Oxitriptan,Proton_coupled_amino_acid_transporter_1-Inhibitor
1418,C=C[C@@H](N)CCC(=O)O,negative,N[C@@H](CCC(O)=O)C=C,Vigabatrin,Proton_coupled_amino_acid_transporter_1-Substrate
1419,COc1cc2nc(N(C)CCCNC(=O)[C@H]3CCCO3)nc(N)c2cc1OC,negative,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)[C@H]3CCCO3,Alfuzosin,3A4-Substrate
1420,C=CC[C@]1(O)CC[C@H]2[C@H]3CCC4=CCCC[C@H]4[C@@H]3CC[C@]21C,negative,C[C@@]12CC[C@@H]3[C@H](CCC4=CCCC[C@@H]34)[C@@H]1CC[C@@]2(O)CC=C,Allylestrenol,3A4-Substrate
1421,CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1,negative,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1,Atenolol,3A4-Substrate
1422,N.N.O=C1O[Pt]OC(=O)C12CCC2,negative,N.N.O=C1O[Pt]OC(=O)C12CCC2,Carboplatin,3A4-Inducer
1423,CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,negative,CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C4=CC=C(O)C=C4)[C@H](O)CCN,Caspofungin,3A4-Inhibitor
1424,CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc21,negative,CN(C)CCC=C1/C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,Chlorprothixene,3A4-Substrate
1425,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@H]3[C@@H](O)C[C@]12C,negative,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]3[C@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@H]4[C@@H](O)C[C@@]23C)[C@H]6CCCCC6,Ciclesonide,3A4-Substrate
1426,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O,negative,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N,Dihydrostreptomycin,3A4-Substrate
1427,C[C@@H](CN1c2ccccc2Sc2ccc(S(=O)(=O)N(C)C)cc21)N(C)C,negative,C[C@@H](CN1C2=C(SC3=CC=C(C=C13)S(=O)(=O)N(C)C)C=CC=C2)N(C)C,Dimetotiazine,3A4-Inhibitor
1428,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,negative,ClC1=CC2=C(C=C1)N3C=NN=C3CN=C2C4=CC=CC=C4,Estazolam,3A4-Substrate
1429,C[C@@]12CC[C@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@@H]3[C@@H]1CC[C@@H]2O,negative,C[C@@]12CC[C@@H]3[C@H](CCC4=C3C=CC(OC(=O)N(CCCl)CCCl)=C4)[C@@H]1CC[C@@H]2O,Estramustine,3A4-Substrate
1430,CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O,negative,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,Famciclovir,3A4-Substrate
1431,C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,negative,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC4=CC(O)=CC=C34)[C@@H]1CC[C@@H]2O,Fulvestrant,3A4-Substrate
1432,N=C(N)NCCN1CCCCCCC1,negative,NC(=N)NCCN1CCCCCCC1,Guanethidine,3A4-Inducer
1433,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,negative,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,Hydrocortisone Aceponate,3A4-Substrate
1434,Oc1ccc(O)cc1,negative,OC1=CC=C(O)C=C1,Hydroquinone,3A4-Substrate
1435,O=[N+]([O-])O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12,negative,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O,Isosorbide Mononitrate,3A4-Substrate
1436,COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2,negative,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,Ivabradine,3A4-Substrate
1437,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,negative,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,Levothyroxine Sodium,3A4-Substrate
1438,CC(=O)[C@@]1(C)CC[C@H]2[C@H]3C=C(C)C4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]21C,negative,CC(=O)[C@@]1(C)CC[C@H]2[C@H]3C=C(C)C4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@@]12C,Medrogestone,3A4-Substrate
1439,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,negative,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,Metandienone,3A4-Substrate
1440,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,negative,CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O,Methylprednisolone Aceponate,3A4-Inducer
1441,CCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](OC(=O)CC)CC(=O)O[C@H](C)CC=CC=C[C@H](OC(C)=O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)OC(C)=O,negative,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(C)=O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC,Miocamycin,3A4-Inhibitor
1442,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,negative,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,Pazopanib,3A4-Inhibitor
1443,C[C@H](COc1ccccc1)N(CCCl)Cc1ccccc1,negative,C[C@H](COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,Phenoxybenzamine,3A4-Substrate
1444,CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O,negative,CC1(C)S[C@@H]2[C@H](NC(=O)COC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O,Phenoxymethylpenicillin,3A4-Inducer
1445,CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,negative,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,Pimecrolimus,3A4-Substrate
1446,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,negative,ClC1=CC2=C(C=C1)N(C[C@H]3CC3)C(=O)CN=C2C4=CC=CC=C4,Prazepam,3A4-Substrate
1447,CCCCC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,negative,CCCCC(C(=O)O[C@H]1CCN(C)CC1)(C2=CC=CC=C2)C3=CC=CC=C3,Propiverine,3A4-Inhibitor
1448,CN(C)C(=O)Oc1ccc[n+](C)c1,negative,CN(C)C(=O)OC1=C[N+](C)=CC=C1,Pyridostigmine,3A4-Inducer
1449,CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O,negative,CC[C@H]1NC(=O)[C@@H](NC(=O)C2=NC=CC=C2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@H]3CC(=O)[C@H](CS[C@@H]4CN5CC[C@@H]4CC5)CN3C(=O)[C@H](CC6=CC=C(C=C6)N(C)C)N(C)C(=O)[C@@H]7CCCN7C1=O)C8=CC=CC=C8,Quinupristin/dalfopristin,3A4-Inhibitor
1450,CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,negative,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(C(O)=C3C)C(O)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C5=C4N=C6C=C(C)C=CN56,Rifaximin,3A4-Inducer
1451,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,negative,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,Rufinamide,3A4-Inducer
1452,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,negative,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2,Saxagliptin,3A4-Substrate
1453,O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-],negative,[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,Sodium Edetate,3A4-Substrate
1454,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)C=CC=CC[C@@H](C)OC(=O)C[C@H]1O,negative,CO[C@H]1[C@H](O)CC(=O)O[C@H](C)CC=CC=C[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C,Spiramycin,3A4-Substrate
1455,CC(C)=C[C@@H]1[C@@H](C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C,negative,CC(C)=C/[C@@H]1[C@@H](C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C,Tetramethrin,3A4-Inducer
1456,CC[C@@H]1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21,negative,CC[C@@H]1C(C)=NN=C(C2=CC(OC)=C(OC)C=C2)C3=C1C=C(OC)C(OC)=C3,Tofisopam,3A4-Inhibitor
1457,Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1,negative,CN1C(CC(O)=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2,Zomepirac,3A4-Substrate
1458,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C[C@@H](O)C[C@@H]1O,negative,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C,1_alpha_hydroxy_vitamin_D2,3A4-Substrate
1459,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)C1=O,negative,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)C1=O,9_alpha_fluoro_androstadienedione,3A4-Substrate
1460,CC(C)[C@]12CC(=O)[C@H](C)[C@H]1C2,negative,CC(C)[C@@]12C[C@@H]1[C@@H](C)C(=O)C2,alpha_thujone,3A4-Substrate
1461,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CCC2=O,negative,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,androstenedione,3A4-Substrate
1462,COC(=O)c1c(C)nc(C)c(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)c1-c1cccc([N+](=O)[O-])c1,negative,COC(=O)C1=C(C)N=C(C)C(=C1C2=CC(=CC=C2)[N](=O)=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4,barnidipine_M8,3A4-Substrate
1463,CCO[C@H]1O[C@@H]2OC3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3,negative,CCO[C@H]1O[C@@H]2OC3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,beta_arteether,3A4-Substrate
1464,Oc1ccc(C(c2ccc(O)cc2)C(Cl)(Cl)Cl)cc1,negative,OC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl,bis_OH_methoxychlor,3A4-Substrate
1465,O=C(O)C/C=C/C[C@H]1[C@@H](NS(=O)(=O)c2ccccc2)C2CC[C@@H]1C2,negative,OC(=O)C\C=C\C[C@@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3,bisnor,3A4-Substrate
1466,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,negative,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,budesonide,3A4-Substrate
1467,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1,negative,COCC1=C(C2=CC=C(F)C=C2)C(=C(N=C1C(C)C)C(C)C)\C=C\[C@@H](O)C[C@@H](O)CC(O)=O,cerivastatin,3A4-Substrate
1468,COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)C[C@@H](C)[C@@H](C)C2,negative,COC1=C(OC)C(=C2C(=C1)C[C@H](C)[C@H](C)CC3=CC(=C(OC)C(=C23)OC)OC)OC,deoxy_schizandrin,3A4-Substrate
1469,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H](O)[C@@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H](O)[C@@]1(C)O,erythromycin,3A4-Substrate
1470,CC[S@@](=O)c1c(C#N)nn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c1N,negative,CC[S@@](=O)C1=C(N)[N](N=C1C#N)C2=C(Cl)C=C(C=C2Cl)C(F)(F)F,ethiprole,3A4-Substrate
1471,CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)/C=C\CO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1,negative,CN(C)C1=CC=C(C=C1)[C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)\C=C/CO)[C@@H]4CCC5=CC(=O)CCC5=C24,lilopristone,3A4-Substrate
1472,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@@]21C,negative,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C,lithocholic_acid,3A4-Substrate
1473,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC,negative,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C\C=C\C=C\[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC,miocamycin_Mb2,3A4-Substrate
1474,Nc1ccc(Cc2ccc(N)c(Cl)c2)cc1Cl,negative,NC1=CC=C(CC2=CC=C(N)C(=C2)Cl)C=C1Cl,MOCA,3A4-Substrate
1475,CNCCN1C(=O)[C@H](OC(C)=O)[C@H](c2ccc(OC)cc2)Sc2ccccc21,negative,CNCCN1C(=O)[C@H](OC(C)=O)[C@@H](SC2=C1C=CC=C2)C3=CC=C(OC)C=C3,N_desmethyl_diltiazem,3A4-Substrate
1476,O=NN1CCC[C@H]1c1cccnc1,negative,O=NN1CCC[C@H]1C2=CN=CC=C2,N_nitroso_nornicotine,3A4-Substrate
1477,Clc1ccc(Cl)c(-c2cc(Cl)c(Cl)cc2Cl)c1,negative,ClC1=CC=C(Cl)C(=C1)C2=CC(=C(Cl)C=C2Cl)Cl,PCB_101,3A4-Substrate
1478,OC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,negative,OC(CCCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3,reduced_haloperidol,3A4-Substrate
1479,C/C=C1/C[C@@H](C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23,negative,C\C=C1\C[C@@H](C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23,senecionine,3A4-Substrate
1480,CCn1ncnc1COc1nn2c(-c3ccccc3F)nnc2cc1C(C)(C)C,negative,CC[N]1N=CN=C1COC2=N[N]3C(=NN=C3C4=CC=CC=C4F)C=C2C(C)(C)C,TPA_023,3A4-Substrate
1481,CC(C)(CO)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,negative,CC(C)(CO)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,w_OH_finasteride,3A4-Substrate
1482,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O,negative,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C,1_alpha_hydroxy_vitamin_D3,3A4-Substrate
1483,CCCCOc1ccc2ccc(=O)oc2c1,negative,CCCCOC1=CC=C2C=C[C](=O)OC2=C1,7_butoxy_coumarin,3A4-Substrate
1484,CCCCCCOc1ccc2ccc(=O)oc2c1,negative,CCCCCCOC1=CC=C2C=C[C](=O)OC2=C1,7_hexoxy_coumarin,3A4-Substrate
1485,CCCCCOc1ccc2ccc(=O)oc2c1,negative,CCCCCOC1=CC=C2C=C[C](=O)OC2=C1,7_pentoxy_coumarin,3A4-Substrate
1486,CC(C)[C@]12CC(=O)[C@@H](C)[C@H]1C2,negative,CC(C)[C@@]12C[C@@H]1[C@H](C)C(=O)C2,beta_thujone,3A4-Substrate
1487,C[C@H](CCC(=O)O)[C@@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,negative,C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,chenodeoxycholic_acid,3A4-Substrate
1488,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,negative,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC,clarithromycin,3A4-Substrate
1489,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C,negative,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,deoxycholic_acid,3A4-Substrate
1490,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(C)=O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC,negative,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(C)=O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC,miocamycin_Mb12,3A4-Substrate
1491,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC,negative,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC,miocamycin_Mb6,3A4-Substrate
1492,CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1,negative,CN(C)C1=CC=C(C=C1)[C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]4CCC5=CC(=O)CCC5=C24,onapristone,3A4-Substrate
1493,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](CC)C[C@@]21C,negative,CC[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(O)C#C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@@H]13,org_4060,3A4-Substrate
1494,NC(=O)c1c(Cl)c(-c2cccnc2)n2c1C(O)CCC2,negative,NC(=O)C1=C2C(O)CCC[N]2C(=C1Cl)C3=CN=CC=C3,RPR_127025,3A4-Substrate
1495,C=CCCCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,C[N]1C=NC2=C1[C](=O)[N](CCCCC=C)[C](=O)[N]2C,theobromine_deriv_10,3A4-Substrate
1496,CC/C=C\Cn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CC\C=C/C[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O,theobromine_deriv_11,3A4-Substrate
1497,C=CCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,C[N]1C=NC2=C1[C](=O)[N](CCC=C)[C](=O)[N]2C,theobromine_deriv_12,3A4-Substrate
1498,C=CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,C[N]1C=NC2=C1[C](=O)[N](CCCC=C)[C](=O)[N]2C,theobromine_deriv_13,3A4-Substrate
1499,CCCCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CCCCC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O,theobromine_deriv_4,3A4-Substrate
1500,CCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CCCCCC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O,theobromine_deriv_5,3A4-Substrate
1501,CC(C)CCCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CC(C)CCC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O,theobromine_deriv_6,3A4-Substrate
1502,CCC(C)CCn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CCC(C)CC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O,theobromine_deriv_7,3A4-Substrate
1503,CCCC(C)Cn1c(=O)c2c(ncn2C)n(C)c1=O,negative,CCCC(C)C[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O,theobromine_deriv_8,3A4-Substrate
1504,Cn1cnc2c1c(=O)n(CC1CCCO1)c(=O)n2C,negative,C[N]1C=NC2=C1[C](=O)[N](CC3CCCO3)[C](=O)[N]2C,theobromine_deriv_9,3A4-Substrate
1505,O=[P@]1(N(CCCl)CCCl)OCCCN1CCCl,negative,ClCCN(CCCl)[P@@]1(=O)OCCCN1CCCl,trofosfamide,3A4-Substrate
1506,C[C@H](CCC(=O)O)[C@@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,negative,C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,ursodeoxycholic_acid,3A4-Substrate
1507,CC(C)(C=O)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,negative,CC(C)(NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C)C=O,w_aldehyde_finasteride,3A4-Substrate
1508,CCN(CC)C(=O)Nc1ccc(OC[C@@H](O)CNC(C)(C)C)c(C(C)=O)c1,negative,CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)(C)C)C=C1,Celiprolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate
1509,CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(=O)O,negative,CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,Unoproston,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate
1510,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,positive,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Betamethason,SUL-Inducer
1511,C=C1C(=CC=C2CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O,positive,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C,Calcitriol,SUL-Inducer
1512,CSCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O,positive,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O,Corticotropin,SUL-Inducer
1513,CCOCC,positive,CCOCC,Diethyl Ether,SUL-Inducer
1514,CNC[C@H](O)c1ccc(O)c(O)c1,positive,CNC[C@H](O)C1=CC(O)=C(O)C=C1,Epinephrine,SUL-Inducer
1515,C[C@@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@H]2O,positive,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O,Estradiol,SUL-Inducer
1516,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,positive,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23,Hydrocortisone,SUL-Inducer
1517,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc3ccccc3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)NC1=O)C(C)C,positive,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,Insulin (human),SUL-Inducer
1518,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,positive,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O,Methotrexate,SUL-Inducer
1519,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,positive,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,Progesterone,SUL-Inducer
1520,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C,positive,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C,Promegestone,SUL-Inducer
1521,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,positive,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3,Tamoxifen,SUL-Inducer
1522,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,positive,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Testosterone,SUL-Inducer
1523,C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C,positive,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13,Tibolone,SUL-Inducer
1524,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,positive,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,Triamcinolone,SUL-Inducer
